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Acinetobacter baumannii has emerged as an important, multidrug resistant (MDR) pathogen
causing a wide spectrum of disease conditions in humans. The emergence of multi-drug, pandrug resistant, and extended drug-resistant strains of A. baumannii, which are resistant to almost
all classes of antibiotics, makes the treatment of A. baumannii infections difficult. The ubiquitous
presence of A. baumannii in water and soil along with its ability to persist under various
environmental conditions aids in the potential contamination of foods, especially fresh produce.
Further, the genotypic and phenotypic similarities among various species of Acinetobacter
impede the specific detection of A. baumannii in clinical and environmental samples.
In this dissertation, the prevalence of A. baumannii on fresh vegetables collected from
farmers’ markets in Connecticut was studied. The results showed the presence of a variety of
MDR opportunistic pathogens, including A. baumannii on vegetables. In addition, the effect of
chlorine, a commonly used disinfectant in water, was tested for its efficacy in killing A.
baumannii, besides determining its effect on the antibiotic resistance genes in the bacterium.
Chlorine was not only found ineffective to inactivate significant populations of A. baumannii in
water, but also induced the expression of major antibiotic resistance genes in the pathogen.
A real-time quantitative PCR targeting a highly conserved 102-bp DNA sequence in adeT,
an efflux pump gene found only in A. baumannii, was developed for rapid and specific detection
of the bacterium in water and blood. The PCR detected all the A. baumannii isolates by

amplifying a 107-bp DNA fragment, however, none of the tested negative isolates, including
other closely related Acinetobacter species produced any amplification. The sensitivity of PCR
for detecting A. baumannii in blood and water was 3 log10 CFU/ml or 0.1 ng/ml of DNA.
However, with an enrichment step, the PCR was able to detect 2 log10 and 1 log10 CFU/ml of A.
baumannii in water after 6 h and 14 h of incubation at 37oC, respectively.
Because of A. baumannii’s resistance to most of the currently used antibiotics, this
dissertation also investigated the efficacy of two plant-derived antimicrobials (PDAs), transcinnamaldehyde (TC) and eugenol (EG) in reducing its resistance to seven commonly used βlactam antibiotics. Both TC and EG were effective in significantly increasing the sensitivity of
A. baumannii to the selected beta-lactam antibiotics. Further, it was revealed that TC and EG
down-regulated the expression of major genes conferring antibiotic resistance in the bacterium.
A. baumannii has been increasingly linked to persistent wound infections, especially in
burn victims and combat-related injuries. A. baumannii’s multi-drug resistance and ability to
form biofilms and colonize skin epithelial cells limit the efficacy of currently used wound
infection treatments. Therefore, this dissertation determined the efficacy of TC and EG in
decreasing A. baumannii adhesion to and invasion of human keratinocytes, in addition to
inhibiting A. baumannii biofilm formation using an in vitro wound model. Both TC and EG
significantly reduced A. baumannii colonization of skin cells, and biofilm production, suggesting
their potential application in treating A. baumannii wound infections.
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INTRODUCTION
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1. INTRODUCTION
Bacterial antimicrobial resistance has emerged as one of the most serious public health threats
globally. The Centers for Disease Control and Prevention (CDC) reported that antibiotic-resistant
infections account for two million illnesses and 23,000 deaths annually in the US, with over $20
billion as direct health-care costs and $35 billion in lost productivity (CDC, 2013). The problem
is further exacerbated by the lack of new and effective antibiotics under development against
multi-drug resistant (MDR) pathogens (Maragakis and Perl, 2008; Manchanda et al., 2010).
Acinetobacter baumannii has emerged into a significant MDR pathogen, especially linked to
infections associated with hospitals and intensive care units (Giamarellou, 2010; Medell et al,
2013). The Infectious Diseases Society of America has ranked A. baumannii as one of the top
priority, antibiotic-resistant pathogens to target, due to its rapid propensity to develop drug
resistance, and the restricted choice of antibiotics to treat infections caused by the bacterium
(Talbot et al., 2006). In humans, MDR A. baumannii causes a variety of infections, including
pneumonia (Leung et al., 2006), blood-stream infections (CDC, 2004; Wisplingoff et al., 2004),
meningitis (Metan et al., 2007), and urinary tract infections (Gaynes and Edwards, 2005). In
addition, MDR A. baumannii has been increasingly linked to wound infections in burn victims
(Bergogne-Berezin, 1995; Santucci et al., 2003; Sharma, 2007), and combat-related wound
injuries (Scott et al., 2007; Murray and Hospenthal, 2008).
A. baumannii is ubiquitously distributed in nature because of its ability to persist under a
wide variety of environmental conditions for extended periods of time (Maragakis and Perl,
2008). Acinetobacter spp., including A. baumannii are frequently isolated from soil and water
(Baumann et al; 1968; Berlau et al., 1999; Houang et al., 2001; Dijkshoorn et al., 2007;Cateau et
al., 2011), thereby potentially serving as a source of food contamination, especially fruits and
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vegetables. Protozoans such as Acanthamoeba are reported to support A. baumannii growth in
aquatic ecosystems, and act as a reservoir of the pathogen (Cateau et al., 2011). A limited
number of studies conducted outside the United States have isolated A. baumannii and other
Acinetobacter spp. from a variety of foods, including bulk tank milk (Gurung et al., 2013), raw
meat (Houang et al., 2001; Lupo et al., 2014), fresh produce (Berlau et al.,1999), and fish
(Houang et al., 2001). Since fruits and vegetables are more vulnerable to contamination by
antibiotic resistant bacteria from soil and water due to their cultivation patterns, and are not
generally subjected to any terminal lethal process or cooking, the potential for transfer of
resistant determinants to commensal or pathogenic bacteria in the human gut is greater.
The detection of A. baumannii by conventional bacteriological methods requires at least 48
to 72 h for obtaining accurate results (Levi et al., 2003; Jamal et al., 2014). Furthermore, the four
Acinetobacter species grouped under A. baumannii -A. calcoaceticus complex (ABC),including
A. calcoaceticus, A. baumannii, A. pitti

and A. nosocomalis, are phenotypically and

genotypically closely related, and are difficult to be distinguished from each other. Further,
species identification using biochemical tests fails to differentiate A. calcoaceticus from A.
baumannii, and specific detection needs to be followed up by further tests, which could be time
consuming in clinical diagnosis. Thus, there is a need for rapid and accurate assays for specific
detection of A.baumannii in clinical and environmental samples.
A. baumannii is resistant to most of the currently available antibiotics (Hsueh et al., 2002;
Lin et al 2014). Further, A. baumannii possesses almost all known antibacterial resistance
mechanisms reported in bacteria, including the ability to acquire multidrug-resistance from other
bacteria through plasmids, transposons and integrons, reduced permeability of outer membrane
to some antibiotics, and the constitutive expression of efflux pumps (Vila and Pachon, 2008).
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Since there are limited therapeutic options against A. baumannii, there is a critical need to
explore novel strategies for controlling antibiotic resistance in the bacterium.
For centuries, plants have served as a basis for the development of novel drugs, thereby
contributing to human health. Plants are capable of synthesizing a large number of molecules,
most of which are phenolic compounds or their derivatives (Geissman, 1963; Burt 2004; Holley
and Patel, 2005; Savoia, 2012). Plants produce a majority of these compounds as a defense
mechanism against predation by microorganisms and insects (Cowan, 1999). A variety of plantderived polyphenols serve as dietary ingredients as well as active components in a number of
herbal and traditional medicines (Wollenweber, 1988). Several plant-derived essential oils have
demonstrated antimicrobial activity towards a wide range of microorganisms, and several active
components of these oils have been identified (Burt, 2004; Holley and Patel, 2005).
Although considerable literature exists on the antimicrobial properties of several plant
derived antimicrobials (PDAs) on a wide range of microorganisms, relatively limited information
is available on their effect on bacterial antibiotic resistance, especially in Gram-negative
pathogens. Previous research conducted in our laboratory revealed that several PDAs, including
trans-cinnamaldehyde, carvacrol, eugenol and thymol decreased antibiotic resistance in MDR S.
Typhimurium DT 104 (Kollanoor-Johny et al., 2010). Similarly, Chusri et al. (2009) observed
that two plant molecules, ellagic acid and tannic acid when used as adjuvant enhanced the
antimicrobial activity of novobiocin, coumermycin, chlorobiocin, rifampicin and fusidic acid
against A. baumannii.
Based on the published literature and preliminary research conducted in our laboratory, it
was hypothesized that fresh vegetables could be a potential source of MDR A. baumannii, and
chlorine is ineffective as a water disinfectant for killing the bacterium. In addition, it was
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hypothesized that trans-cinnamaldehyde and eugenol reduce MDR A. baumannii’s resistance to
selected β-lactam antibiotics, and could be used for controlling wound infections of A.
baumannii.
The specific objectives include of this dissertation are to
1. Investigate the prevalence of MDR A. baumannii on fresh vegetables collected from farmers’
markets in Connecticut.
2. Determine the effect of chlorine on A. baumannii survival in water and expression of
antibiotic resistance genes
3. Develop a real-time quantitative PCR for specific detection of A. baumannii in water and
blood.
4. Determine the effect of TC and EG on decreasing A. baumannii resistance to β-lactam
antibiotics, and
5. Investigate the efficacy of TC and EG in reducing A. baumannii adhesion to and invasion of
human keratinocytes and controlling wound infections in vitro.
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CHAPTER II

REVIEW OF LITERATURE
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2. REVIEW OF LITERATURE
1. Taxonomy of Acinetobacter
In 1911, a Dutch microbiologist named Beijerinck M.W. isolated a bacterium from soil using a
minimal medium enriched with calcium acetate, and named it as Micrococcus calcoaceticus
(Howard et al., 2012). After 43 years, Brisou and Prevott in 1954, proposed the genus
Acinetobacter to differentiate this bacterium from the motile organisms within the genus,
Achromobacter (Brisou and Prevot, 1954; Towner, 1992). Subsequently extensive acceptance for
the genus Acinetobacter was given following a comprehensive study of Micrococcus calcoaceticus, Alcaligenes hemolysans, Mima polymorpha, Moraxella lwoffi, Herellea vaginicola and
Bacterium anitratum by Baumann et al. (1968). The conclusion of this study was that the above
organisms belonged to a single genus, and further sub-classification into different species based
on phenotypical characteristics was not possible. The results of Baumann’s 1968 publication
regarding the genus Acinetobacter was later officially acknowledged by the sub-committee on
the Taxonomy of Moraxella and Allied Bacteria (Lessel, 1971).
In the Bergey’s Manual of Systematic Bacteriology (Lautrop,1974), the genus
Acinetobacter was listed with the description of a single species Acinetobacter calcoaceticus, the
type strain being A. calcoaceticus ATCC 23055. However, in the “Approved list of bacterial
names” two different species, A. calcoaceticus and A. lwoffii were included considering the
ability of some Acinetobacters to acidify glucose, whereas others did not (Skerman, 1980). The
current definition of the genus Acinetobacter is Gram-negative, strictly aerobic, non-fermenting,
non-fastidious, non-motile, catalase-positive, oxidase-negative bacteria with a DNA G + C
content of 39 to 47% (Albrecht et al., 2006). Currently, based on the DNA-DNA hybridization
studies made by Bouvet and Grimnot in 1986, the genus Acinetobacter consists of 26 named
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species and nine genomic species (Di Nocera, 2011). Acinetobacter species have phenotypic
similarities and are difficult to differentiate among A. calcoaceticus, A. baumannii,
Acinetobacter genomic species 3 and Acinetobacter genomic species 13TU (Gerner-Smidt, et al
1991).
The genus Acinetobacter is now classified in the family Moraxillaceae. The important
genera within Moraxillaceae include Moraxella, Acinetobacter, Psychrobacter, and related
organisms (Rossau et al., 1991). Acinetobacter genomospecies 2 (A. baumannii) is the principal
pathogen associated with human diseases (Seifert et al., 1993; Gales et al., 2001). In addition,
less frequently reported pathogenic species such as Acinetobacter calcoaceticus (formerly
Acinetobacter genomospecies 1), Acinetobacter pittii (formerly Acinetobacter genomospecies 3)
and Acinetobacter nosocomalis (formerly Acinetobacter genomospecies 13TU) are included in
the genus. These bacteria together with A. baumannii are commonly referred to as A. baumanniicalcoaceticus complex due to their close genotypic similarity and the difficulty in differentiating
by normal phenotypic methods (Seifert et al., 1993; Houang et al., 2001),
Although substantial progress has been achieved in the species level identification of
Acinetobacter, several problems and inconsistencies still exist in the process. In the currently
described DNA–DNA hybridization groups, only 17 of them have valid names. The remaining
hybridization groups were considered too small (< 10 strains) to describe their characteristics as
a group, and the criteria for phenotypic differentiation were inadequate (Bouvet and Grimont,
1986; Bouvet and Jeanjean, 1989; Tjernberg and Ursing, 1989; Gerner Smidt and Tjernberg,
1993; Peleg et al., 2008). Therefore, no definite species names were provided (Bouvet and
Grimont, 1986; Bouvet and Jeanjean, 1989; Tjernberg and Ursing, 1989; Gerner- Smidt and
Tjernberg, 1993). These limitations in species identification methods of Acinetobacter are
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considered an impediment for elucidating the biology, pathogenicity and ecology of the
organism at the species level.
2. Morphology, physiological and biochemical characteristics
The Acinetobacter is identified as Gram-negative, catalase-positive, oxidase-negative,
non-motile, non-fermenting coccobacilli. Although Acinetobacter is considered as non-motile,
there are reports on differential motility in response to factors, including illumination (Mussi et
al., 2010), quorum sensing (Clemmer et al., 2011), and iron chelation (Eijkelkamp et al., 2011).
Although not decisively proven, Acinetobacter spp. can move on semi-solid surfaces by
expressing twitching motility rather than gliding, sliding, swimming, or swarming motility
(Barker and Maxted, 1975; Henrichsen, 1984; Eijkelkamp et al., 2011). When subjected to Gram
staining, the bacteria are often difficult to de-stain and are incorrectly identified as Grampositive. Currently there are no well-defined and definite metabolic tests for distinguishing
Acinetobacter from other non-fermenting Gram-negative bacteria (Peleg et al., 2008). However,
for the differentiation of Acinetobacter from other similar non-fermenting organisms, the
negative oxidase test is used for rapid presumptive identification.
Acinetobacter can be easily grown on simple microbiological media and the colony
characteristics include smooth, dome shaped, pale yellow to grayish, and with entire edge (Doi et
al 2011). The colonies of A. calcoaceticus-A. baumannii complex can grow to a size of 1.5 to 3
mm in diameter in an overnight culture similar to that of Enterobacteriaceae, whereas majority
of other Acinetobacter species produce smaller colonies (Peleg et al., 2008). Although most
Acinetobacter species can grow at ambient temperatures, the pathogenic species, A. baumannii
grows very well at 37℃. For recovering Acinetobacter isolates from complex samples,
enrichment medium such as Leeds selective medium is used (Doi et al., 2011). However,

9

Baumann et al (1968) reported that Acinetobacters from environmental and clinical specimens
could be recovered by growing aerobically in an acidic enrichment medium containing acetate as
a carbon source and nitrate as nitrogen source. A. baumannii has been reported to possess a thick
cell wall which protects the organism from dry conditions, besides providing high tolerance to
temperature, pH and nutrient changes (Vila et al., 2007; Kramer et al., 2006; Houang et al.,
1998).
3. Natural Habitats and Sources
Water and soil are considered as major habitats of A. baumannii although the pathogen
has been isolated from other sources, including foods, arthropods, animals, and humans
(Baumann et al 1968; Berlau et al., 1999; Mussi et al., 2005; Fournier and Richet, 2006; MunozPrice and Weinstein, 2008). Moreover, protozoans such as Acanthamoeba are reported to support
the growth of A. baumannii, and act as its reservoir in water (Cateau et al 2011). Recently,
studies indicated the potential presence of A. baumannii in water systems from multiple parts of
the world (Catel-Ferreira et al., 2011; Zhang et al., 2013).
Although a limited number of studies have revealed the presence of A. baumannii on a
variety of foods, the pathogen has not been implicated in any food-borne disease outbreaks. In a
study conducted in South Korea, A. baumannii strains showing different antimicrobial resistance
patterns were isolated from bulk tank milk (Gurung et al., 2013). Out of the 2,287 bulk tank milk
(BTM) sampled from different provinces in Korea, Acinetobacter spp. were isolated from 176
BTM samples, of which 57 isolates were identified as A. baumannii. The presence of
Acinetobacter spp. in BTM has been attributed to the contamination from environmental sources
such as teat, udder surfaces, milking machines, and contaminated water used for cleaning. This
could represent a potential source for resistance genes as they may survive pasteurization (Jain
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and Danziger, 2004). Similarly, the isolation of Acinetobacter spp. from goat milk samples from
Kenya at a rate of 5% was reported (Ndegwa et al., 2001).
Berlau and colleagues (1999), while studying the prevalence of Acinetobacter spp. in
fresh produce in the United Kingdom, reported that 17% of the samples tested positive for the
bacteria, including A. baumannii. These investigators observed that 56% of the Acinetobacter
belonged to A.baumannii-calcoaceticus group, which were found on apple, melon, bean,
cabbage, cauliflower, carrot, potato, radish, lettuce, cucumber, pepper, mushroom, and sweet
corn. Houang et al. (2001) found A. baumannii and genomospecies 3 on vegetables, pork, beef,
and freshwater fish procured from local markets in Hong Kong. Acinetobacter spp. was present
in 27 of the 36 meat samples, 21 of 41 vegetable samples, and 26 of 38 fish samples screened. In
another study, Gennari and Lombardi (1993) observed that out of 170 strains isolated from
foods, including fresh and spoiled meat and fish, vegetables, raw milk and cheese, A. lwoffii was
confirmed in over half of the isolates, whereas 11% and 5% of the isolates were A. johnsonii and
A. baumannii, respectively indicating that foods could be a potential source of A. baumannii. In a
recent study from Switzerland, Lupo et al. (2014) isolated A. baumannii from 25% of the meat
samples, where 48 % of the positive food samples were poultry meat. The isolated strains
displayed resistance to third and fourth generation cephalosporins, which are currently used for
treating human infections.
A. baumannii has been reported to colonize the skin, nostrils, and throat of healthy people
(Seifert, et al., 1997; Chu et al., 1999; Dijkshoorn et al., 2005; Montefour et al., 2008). A
common route for spread of A. baumannii in the hospital environment has been reported to be
unclean hands of the hospital staff (Jalalpour and Abdol, 2012). Further, it has been indicated
that A. baumannii strains once colonized can remain for weeks in the body of patients
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(Dijkshoorn et al., 2007).Therefore, stringent personal hygiene and cleanliness are critical for
preventing the pathogen transmission (Allegranzi et al., 2009). Besides humans, La Scola and
Raoult (2004) reported that 22% of body lice sampled from homeless people tested positive for
A. baumannii, thereby suggesting that these parasites could also act as a potent reservoir of the
pathogen.
Another major source of A. baumannii is the hospital environment, where its persistence
is attributed to the ability to grow under various temperatures and pH conditions, and more
importantly to tide over unfavourable conditions such as desiccation, nutrient starvation and
treatment with disinfectants (Wendt et al., 1997; Perez et al., 2007; Wisplinghoff et al., 2007;
Gaddy and Actis, 2009). This is achieved by the ability of A. baumannii to form biofilms on
abiotic surfaces in the hospital environment, which protects the pathogen from disinfectants,
thereby helping it to persist for a long duration and act as a permanent source of infection
(Gaddy et al., 2009; Shin et al., 2009; Moultrie et al., 2011; Pour et al., 2011). In health-care
environments, a variety of surfaces, including tabletops, bed rails, sinks, door handles, floors,
mattresses, and pillows are implicated as potential sources of A. baumannii (Wilks et al., 2006;
Karageorgopoulos and Falagas, 2008). It was reported that the use of contaminated medical
devices such as catheters, sutures, ventilators can also serve as A. baumannii sources in hospitals
(Montefour et al., 2008; Rao et al., 2008; Lee et al., 2008), and lead to subsequent colonization
of the organism in the respiratory tract, blood, pleural fluid, urinary tract, surgical wounds, skin
and eyes of patients (Bayuga et al., 2002; Gusten et al., 2002; Lorente et al., 2004). Thus the
persistence of A. baumannii in the hospital environment is regarded as the most important factor
aiding in the transmission of infection in nursing homes and nosocomial settings (Denton et al.,
2005; Rastogi et al., 2007; Karageorgopoulos and Falagas, 2008).
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4. Pathogenicity of Acinetobacter infections and virulence
The pathogenesis of A. baumannii infections is not completely understood, and hence the
mechanisms involved in its colonization, infection and systemic spread are yet to be fully
elucidated. A number of putative mechanisms having specific roles in colonization, infection and
epidemic spread have been illustrated. These mechanisms include adherence to host cells,
resistance to desiccation, disinfectants, and antibiotics, biofilm formation, quorum sensing, and
elicitation of inflammatory responses and cytotoxicity (Dijkshoorn et al., 2007).
Bacterial adherence to epithelial cells is a critical initial step in the process of
colonization and infection (Beachey, 1981). The study conducted by Choi et al. (2008) found
that A. baumannii has the potential to invade epithelial cells and its invasion of cells varies with
the type of host cells. It was observed that respiratory tract epithelial cells were the most
susceptible to invasion by A. baumannii compared to other epithelial cells. The various known
virulence factors potentially contributing to A. baumannii pathogenesis are discussed below.
4.1. Cell surface hydrophobicity and enzymes
A. baumannii possesses significant cell hydrophobicity, which helps it adhere to host
cells and evade phagocytosis, besides helping in successful attachment to plastic or polymer
surfaces such as catheters (Doughari et al., 2011). The presence of a rough cell surface and
protein protrusion on the surface of Acinetobacter reportedly confers hydrophobicity (Phuong et
al., 2009; Rosenberg et al., 1980). In addition, cell surface enzymes have been found to influence
the hydrophobicity in A. baumannii. Boujaafar et al. (1990) observed that A. baumannii isolates
from catheters and tracheal devices possessed a greater hydrophobicity than environmental
isolates.
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4.2. Toxic slime polysaccharides
The production of toxic slime polysaccharides in Acinetobacter spp. have been reported
by Hoštacká (2002). These polysaccharides are composed of glucose building blocks, glucuronic
acid, D-mannose, L-ramnose and D-glucose, which are produced during the exponential stage of
A. baumannii growth. Besides exerting a toxic effect on neutrophils, the slime inhibits their
migration and phagocytosis. Moreover, capsular polysaccharides produced by A. baumannii help
the bacterium in evading the host immune response, and growing in serum (Russo et al., 2011).
In general, slime producing Acinetobacter strains have been found to be more virulent than nonproducers (Obana, 1986).
4.3. Outer membrane protein
Outer membrane proteins (Omp) play an important in the pathogenesis of many Gramnegative bacteria. Outer membrane protein A (OmpA, 38 kDa) has been identified in several
strains of Acinetobacter, especially A. baumannii (Dijkshoorn, et al., 2007; Gordon and
Wareham, 2010). During infection, A. baumannii OmpA binds to eukaryotic cells and
subsequently gets translocated into the nucleus, causing cell death (Dorsey et al., 2003;
Dijkshoorn et al., 2007; Choi et al., 2008). It was also shown that OmpA of A. baumannii
induces early onset of apoptosis and delays necrosis in dendritic cells. In addition, OmpA has
been reported to play a role in biofilm formation, surface motility and serum resistance in A.
baumannii (McConnell et al., 2013). Besides OmpA, Omp33-36 is another outer membrane protein
shown to be critical for A. baumannii virulence by inducing apoptosis of host cells by activation
of caspases and modulation of autophagy (Rumbo et al., 2014). In addition, cell surface
components such as adhesins and fimbriae (pili) have been reported to play a role in A.
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baumannii attachment to host cell as well as inanimate surfaces (Smith et al., 2007; Braun, 2008;
Musafer and Essa, 2013; Eijkelkamp et al., 2013).
4.4. Surface and mitochondrial porins
Porins are proteins that form channels enabling the transport of molecules across the lipid
bilayer membrane of bacterial cells. Depending upon the bacterial species, porins play an
important role in the maintenance of cellular structural integrity, bacterial conjugation,
bacteriophage binding and antimicrobial resistance (Vaara et al., 1992). Moreover, pore
formation facilitates the passage of small molecules into the bacterial cell (Braun, 2008). Pores
as outer membrane structures, are an important part of efflux pumps, thereby aiding in the
exclusion of toxic materials from the cell. Vila et al. (2007) indicated that porins in A. baumannii
coupled with efflux pumps create an important barrier for the uptake of antibiotics.
4.5. Siderophores
The capacity of a bacterium to acquire iron for its growth in a host is considered as a
critical virulence determinant. Siderophores are host iron-binding proteins which assist in iron
uptake by the producing bacteria. Acinetobacter siderophores are called as acinetobactins
(Mihara et al., 2004). Acinetobacters are capable of synthesizing siderophores, which can
convert polymeric ferric oxy-hydroxides to soluble iron chelates under low iron stress (Neilands,
1995). A. baumannii can acquire ferric ions under limited iron conditions through siderophores,
and this is reported to play a critical role in its virulence. Gaddy et al. (2012) observed that
acinetobactin mediated iron acquisition system in A. baumannii resulted in human epithelial cell
damage and mortality in Galleria mellonella caterpillars and infected mice. Further, clinical
strains of A. baumannii have been found to grow under iron deficient conditions, and were
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shown to excrete an iron-regulated catechol siderophore into culture supernatants (Echenique et
al., 1992; Actis et al., 1993).
In addition to the aforementioned virulence factors, a variety of enzymes produced by A.
baumannii have been reported to a play role in its virulence. For example, mutants of A.
baumannii in phopsholipases were found to possess decreased serum resistance and invasion of
host cells, and reduced pathogenesis in a murine model of pneumonia (Jacobs et al., 2010; Stahl
et al., 2015). Similarly, enzymes such as butyrate esterase, caprylate esterase, and leucine
arylamidase are believed to be involved in the hydrolysis of short chain fatty acids, thereby
causing damage to host tissue lipids (Jolly-Guillou and Brun Buisson, 1996; Rathinavelu et al.,
2003; Towner, 2006).

Besides these factors, biofilm formation and antibiotic resistance

contribute to A. baumannii virulence.
5. Biofilm Formation
Biofilm is a complex material, composed of microorganisms attached to surfaces and
enclosed in a hydrated polymeric matrix of three dimensional structures. The matrix comprises
of polysaccharides, proteins and nucleic acids (Vidal et al., 1996; Costerton et al., 1999; Sauer et
al., 2007). A. baumannii can persist for prolonged periods of time in the hospital environment in
biofilms, thereby insulating it from disinfectants, and serving as a continuous source of infection.
Besides increasing the potential for nosocomial spread, biofilm production in A. baumannii also
contributes to antibiotic resistance. The adherence of A. baumannii to biotic and abiotic surfaces
facilitates the development of biofilms, which is responsible for the persistence of the pathogen
in medical settings as well as development of resistance to antibiotics (Donlan and Costerton,
2002; Gaddy and Actis, 2009). The major factors that regulate biofilm synthesis in A. baumannii
include nutrient availability, surface structures such as pili, outer membrane proteins, quorum
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sensing, and macromolecular substances such as DNA and polysaccharides (Gaddy and Actis,
2009; Cerqueira and Peleg, 2011).
A. baumannii pili are encoded by the csu/BABCDE chaperone-usher assembly system,
which is controlled by a two-component regulatory system encoded by bfmS and bfmR
(Cerqueira and Peleg, 2011; Luo et al., 2015). Transposon mutagenesis revealed that csuA and
csuE are critical for bacterial attachment, biofilm production and pili synthesis (Tomoaras et al.,
2003). Subsequent research by the same researchers indicated that inactivation of bfmR response
regulator led to absence of csu expression, with a lack of pili production and biofilm formation in
A. baumannii. However, mutation in bfmS was found to impair biofilm synthesis only partially.
Another surface protein called biofilm-associated protein (Bap) is also associated with biofilm
production in A. baumannii; mutation of this gene reduced biofilm thickness by more than 50%
compared to wild type (Loehfelm, 2008). Similarly, OmpA has been found to be critical for
forming thick biofilms, especially on polystyrene surface (Gaddy et al., 2009). In addition,
exopolysaccharides, particularly poly-β-(1-6)-N-acetylglucosamine (PNAG) have been reported
to be necessary for the integrity of A. baumannii biofilms formed under dynamic and stressful
environments (Choi et al., 2009). Further, PNAG is believed to play a role in cell-to-cell
adhesion (Cramton et al., 1999). Besides the aforementioned factors, quorum sensing, a wellstudied cell-to-cell communication mechanism in bacteria, has also been observed to regulate
biofilm synthesis in A. baumannii. The quorum sensing molecule, 3-hydroxy-C12-HSL, encoded
by the autoinducer synthase gene, abaI is critical for later stages of biofilm production,
especially on abiotic surfaces (Niu et al., 2008).
Several researchers have observed that the clinical isolates of A. baumannii are found to
be strong biofilm formers (Rodriguez-Baño et al., 2008; King et al., 2009; Eijkelkamp et al.,
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2011; Gurung et al., 2013). Besides increasing the potential for nosocomial spread, biofilm
production in A. baumannii contributes to antibiotic resistance and increased virulence. For
example, clinical isolates of MDR A. baumannii demonstrated a strong ability to produce
biofilms, which correlated to increased attachment to human bronchial epithelial cells (Lee et al.,
2008; Rao et al., 2008; Shin et al., 2009; Gordon et al., 2010). Therefore, inhibiting biofilm
production in A. baumannii is crucial for controlling its transmission in hospitals as well as
reducing its antibiotic resistance and virulence.
6. Clinical manifestations of A. baumannii infections
Being an opportunistic pathogen, A.baumannii generally affects critically ill patients in
intensive care units (ICUs), specifically those depended on mechanical ventilation or in patients
with wound or burn injuries. It causes infections like ventilator-associated pneumonia, skin and
soft-tissue wound infections, urinary tract infections, peritonitis, secondary meningitis and
bloodstream infections (Bergogne-Bérézin and Towner, 1996; Peleg et al., 2008). The major risk
factors that predispose to A. baumannii infection include prolonged period of hospitalization,
residence in an intensive care unit, receipt of mechanical ventilation, use of central venous or
urinary catheters, exposure to broad-spectrum antimicrobial agents, recent surgery, invasive
procedures, and underlying disease conditions (Saulnier et al., 2001; Fournier et al., 2006;
Playford et al., 2007; Montefour et al., 2008). However, the persistence of A. baumannii in the
hospital environment is the most important factor aiding in the transmission of infection in
nursing homes and nosocomial settings (Simor et al., 2002; Denton et al., 2005; Rastogi et al.,
2007). In addition, community-acquired A. baumannii pneumonia Guner et al., 2011; Silva et
al., 2012), bacteremia (Obaro et al., 2011), urinary tract infection (Solak et al., 2011), and
meningitis (Ozaki et al., 2009) have been reported.
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Hospital acquired pneumonia was reported to be 15% of all nosocomial infections, with
A. baumannii being considered as an important pathogen associated with high mortality in
patients suffering from pneumonia (Fagon et al., 1989; Timsit et al., 1996). A report from the
Centers for Disease Control and Prevention (CDC) showed that the percentage of incidence of
Acinetobacter-associated ICU-acquired pneumonia increased from 4% in 1986 to 7% in 2003
(Gaynes and Edwards, 2005). This is of concern especially in immunocompromised patients
admitted to ICUs and in surgical wards. The high incidence of hospital-acquired pneumonia is
attributed to the use of A. baumannii contaminated ventilators and endotracheal tubes (Cefai et
al., 1990; Bernards et al., 2004). Pneumonia caused by Acinetobacter are similar to those caused
by Gram-negative bacteria, with symptoms such as fever, leukocytosis, purulent sputum
production and appearance of new infiltrates on radiograph or CT scan. Further, the pathogen
could be isolated from bronchial brushings (Chaste et al., 1996).
A. baumannii has been reported as the tenth most common etiologic agent causing
nosocomial ICU-acquired bloodstream infections (BSI) in the United States (Wisplinghoff,
2000). The overall mortality from A. baumannii BSIs ranges from 34 to 43% in the ICU and
16% in patients outside the ICU (Peleg et al., 2008). In a study investigating the clinical and
epidemiological features of nosocomial BSIs caused by Acinetobacter species at 49 US hospitals
during the period from March 1995 through February 1998, Wisplingoff et al. (2000) reported
that Acinetobacter species were found in 24 hospitals (49%) accounting for 1.5% of all
nosocomial BSIs. Of the 129 Acinetobacter isolates, 111 were A. baumannii and 18 belonged to
other Acinetobacter species.

In addition, 30% of the isolates were resistant to multiple

antibiotics. A report from South Korea indicated that A. baumannii was responsible for 112 cases
of bacteremia in patients, whereas other Acinetobacter species such as A. lwoffii, A.
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haemolyticus, and A. calcoaceticus were the causative agents of BSI in 28 patients (Choi et al.,
2006).
Although A. baumannii rarely causes meningitis in community settings, it is increasingly
reported to be associated with post-neurosurgical meningitis, especially with mortality rates as
high as 64% (Garcia-Garmendia et al., 2001). In a study involving 281 adult patients with
nosocomial bacterial meningitis, 3.6% were diagnosed with Acinetobacter spp. meningitis (Kim
et al., 2009). Likewise, two studies from Turkey reported Acinetobacter spp. as the leading
cause of Gram-negative post-neurosurgical meningitis (Sacar et al., 2006; Metan et al., 2007).
Frequent distribution of Acinetobacter species on human skin has been reported to
predispose infections involving skin and soft tissues (Seifert et al., 1997). A. baumannii was
found responsible for 2.1% of ICU–acquired skin/soft tissue infections (Gaynes and Edwards,
2005). A. baumannii was also isolated from wounds of combat casualties from Iraq and
Afghanistan (Scott et al., 2007; Murray and Hospenthal, 2008; Peleg et al., 2008). In addition, A.
baumannii is associated with persistent wound infections in burn victims with delayed wound
healing (Bergogne-Berezin, 1995; Santucci et al., 2003; Sharma, 2007).Besides the above
conditions, A. baumannii has been implicated in catheter-associated urinary tract infections
(Gaynes and Edwards, 2005), endocarditis (Olut and Erkek, 2005; Menon et al., 2006), and eye
infections (Kau et al., 2002; Levy et al., 2005).
7. Antibiotic resistance
Acinetobacter is considered multi-drug resistant (MDR) if it is resistant to at least three
classes of antimicrobial agents. A.baumannii has emerged into a MDR bacterium difficult to treat
due to its resistance to most of the currently available antibiotics. In fact, it is often viewed as the
most difficult antimicrobial-resistant Gram-negative bacillus to control and treat (Maragakis and
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Perl, 2008). Carbapenems were once the first choice antibiotics for treating A. baumannii, but are
no longer completely effective due to resistance development by the bacterium (Falagas and
Karaveli 2007; Bassetti et al., 2008). Similarly, polymyxins were successfully used to treat A.
baumannii infections a few years ago, however, strains resistant to these drugs have also evolved
(Hernan et al., 2009). Thus, the resistance of A. baumannii to multiple antibiotics presents a great
challenge for health-care professionals for controlling infections associated with this pathogen.
A. baumannii possesses a variety of antibacterial resistance mechanisms. These
mechanisms include intrinsic and extrinsic ones, and multiple factors are reported to favour the
acquisition of multidrug-resistance in A. baumannii (Vila and Pachon, 2008). These include the
ability of the bacterium to persist in environmental and human reservoirs, which aids in the
transfer of genetic materials between other microorganisms and A. baumannii, capacity to
acquire a wide variety of genetic elements, including plasmids, transposons and integrons (Vila
and Pachon, 2008).
Besides

the

intrinsic

mechanisms

conferring

resistance

to

aminopenicillins,

cephalosporins and chloramphenicol, A. baumannii has acquired mechanisms that impart
resistance to β-lactam antibiotics, aminoglycosides, tetracyclines and fluoroquinolones
(Dijkshoorn, et al., 2007). In addition, expression of β-lactam hydrolyzing enzymes, induced
changes in the outer membrane proteins, up-regulation of multiple drug efflux pumps, altered
penicillin binding proteins (PBP), antibiotic modifying enzymes, machineries for modification of
antibiotic target binding sites, ribosomal protection, and porin channel deletions have also been
reported in A. baumannii (Gordon and Wareham., 2010).
The transportation of antimicrobial agents into the bacterial cell and their subsequent
effect are controlled by porin channels and other outer membrane proteins in bacteria. The lack
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of these outer membrane proteins and channels, thus preventing antimicrobials from reaching
their targets resulting in resistance has been reported in Acinetobacter spp. (Thomson and
Bonomo, 2005; Bou et al 2000; Mussi et al., 2005). Li et al. (2005) reported the development of
colistin resistance in Acinetobacter due to changes in the bacterial membrane that hinder the
action of the antibiotic on the bacterial targets.

In addition, the efflux pumps which aid

Acinetobacter spp. in the removal of antimicrobial agents from bacterial cells have been
observed (Bonomo and Szabo, 2006). The efflux pumps are membranes embedded proteins
which function by excluding the antibiotic out of the cell. The reported efflux pump systems
include AdeABC (Magnet et al., 2001), AdeIJK (Damier-Piolle et al., 2008), AdeXYZ (Roca et
al., 2011), AdeM (Su et al., 2005),Tet(A) and Tet(B) (Guardabassi et al., 2000; Ribera et al.,
2003a; Ribera et al., 2003b). Schaack et al. (2010) reported that the over expression of AdeABC
efflux pump causes resistance to cephalosporins, fluoroquinolones, and tigecycline. AbeM efflux
pump confers resistance aminoglycoside and fluoroquinolone (Gootz and Marra, 2008), whereas
Tet(A) and Tet(B) and CmlA encode for resistance to tetracyclines and chloramphenicols,
respectively (Bergogne-Berezin et al., 2008).
Exceeding 50 different degrading enzymes or their allelic forms have been found to
confer resistance to β–lactam antibiotics, including extended spectrum β-lactamases,
oxacillinases and metallo-β-lactamases (Bergogne-Be’re’zini and Towner., 1996). These
multiple β-lactamases confer resistance to different classes of β-lactam antibiotics such as
penicillin derivatives, cephalosporins and carbapenems in A. baumannii. The various classes of
β-lactamases include class A β-lactamases (Nagano et al., 2004; alNaiemi et al.,2005; Pasteran et
al., 2006), class B β-lactamases (metallo β-lactamases) (Chu et al., 2001;Lee et al.,2003; 2005),
class C β-lactamases (eg. Acinetobacter-derived cephalosporinases or the chromosomally-
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encoded AmpC enzymes) (Bou et al 2000) and class D β-lactamases responsible for resistance of
carbapenems through the production of oxacillinases (Peleg et al., 2008). In addition, class A
extended spectrum beta lactamases (ESBLs) are also present in A. baumannii (Vila et al., 1993).
Additionally, the presence of PER-1, an ESBL in A. baumannii which imparts a high level of
resistance to penicillins and extended-spectrum cephalosporins, but not to carbapenems has been
detected (Yong et al., 2003; Sechi et al., 2004; Farajnia et al., 2013).
A few Acinetobacter species expressing VIM and IMP β-lactamases capable of
hydrolyzing different antimicrobial agents, including carbapenems have been detected (Thomson
and Bonomo, 2005). Researchers commented that since the metallo-β-lactamases are located on
mobile genetic elements, the potential for their transfer from one bacterium to another is high
(Thomson and Bonomo, 2005; Bonomo and Szabo, 2006). AmpC cephalosporinases which come
under class C β-lactamases are chromosomally encoded and confer resistance to broad-spectrum
cephalosporins (Thomson and Bonomo, 2005; Bonomo and Szabo, 2006). Similarly, class D
OXA type enzymes (β-lactamases with carbapenem-hydrolysing properties) were also reported
in A. baumannii from various countries (Brown and Amyes, 2006; Afzal-Shah et al., 1999;
Opazo et al., 2011; 2012).
Resistance to aminoglycoside antibiotics through their modification by integronassociated or plasmid-encoded genes, which encode acetyltransferases, nucleotidyltransferases
and phosphotransferases is documented in MDR A. baumannii. Moreover, 16S rRNA
methylation causing impaired binding of gentamicin, tobramycin and amikacin to their target
sites, thereby leading to their resistance is documented (Beceiro et al., 2013). Besides these
machineries, gentamicin and kanamycin can be effluxed out by AbeM efflux pump in A.
baumannii (Vila et al., 2007). Mutations in gyrA and parC resulting in the modification of DNA
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gyrase or topoisomerase IV is the major underlying mechanism for quinolone resistance in A.
baumannii (Park et al., 2011). Chromosomal mutations in the quinolone resistance determining
region (QRDR) of the gyrA and parC, and resulting production of modified bacterial DNA
gyrase and topoisomerase IV enzymes has been reported to confer resistance to quinolones in A.
baumannii (Peleg et al., 2008). A decreased influx and/or increased efflux of quinolones can also
contribute to quinolone resistance (Peleg et al., 2008). However, as an adjunct, involvement of
AdeABC and AdeM pumps also play a role in quinolone resistance (Chopra and Galande.,
2011).
8. Plant-derived antimicrobials
Plant-derived antimicrobials (PDAs) are secondary metabolites produced by plants
possessing potential antibacterial activity against a wide range of microbial pathogens and food
spoilage bacteria (Burt, 2004; Holley and Patel; 2005; Upadhyay et al., 2014). These secondary
metabolites are generally aromatic compounds comprising alkaloids, glycosides, terpenoids,
saponins, steroids, flavonoids, tannins, quinones and coumarins (Das et al., 2010). A majority of
these compounds are produced by plants as a defence mechanism against by microorganisms and
insects (Cowan, 1999). In many cultures, PDAs have been used as dietary constituents and
ingredients in herbal and traditional medicines (Wollenweber and Kinzel, 1988). The general
mechanisms of antimicrobial effect of PDAs include increasing permeability of the bacterial
membrane, disintegration of bacterial cytoplasmic membrane, and destabilization of the proton
motive force, electron flow, active transport and coagulation of the cell content (Burt, 2004).
Trans-cinnamaldehyde (TC) is an aldehyde present in the bark extract of cinnamon.
Trans-cinnamaldehyde has a wide margin of safety between conservative estimates of intake,
with no observed adverse effects, including genotoxic and mutagenic effects from sub chronic
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and chronic studies (Adams et al., 2004). Trans-cinnamaldehyde possesses antimicrobial activity
towards a wide range of Gram-positive and Gram-negative bacteria (Bowles and Miller, 1993;
Bowles et al., 1995; Friedman et al., 2002). Besides the deleterious effect exerted on the bacterial
membrane, TC acts by depleting intracellular ATP by inhibiting ATPase supported energy
metabolism along with inhibition of glucose uptake and its utilization (Gill and Holley,2004;
Oussalah et al.,2006; Negi, 2012). Eugenol (EG) is a natural molecule present as an active
ingredient in the oil from cloves (Eugenia caryophillis) (Ali et al., 2005; Yadav et al., 2013). The
antibacterial activity of clove oil and eugenol has been documented by many researchers (Menon
and Garg, 2001; Hyldgaard et al., 2012). Eugenol has been found to cause cell wall degradation
and cell lysis in bacteria (Thoroski, 1989). Both TC and EG are classified as GRAS by the FDA
(TC, 21 CFR 182.60 (CFR, 2011a); EG, 21 CFR 582.60 (CFR, 2011b).
Although considerable amount of literature exists on the antimicrobial properties of
several PDAs on a wide range of microorganisms, comparatively limited information is available
on their effect on bacterial antibiotic resistance, especially in Gram-negative pathogens. A
handful of studies have revealed that PDAs could be used to potentiate the effect of antibiotics in
bacteria. Previously, Chusri et al. (2009) observed that two plant molecules, ellagic acid and
tannic acid when used as adjuvants enhanced the antimicrobial activity of several antibiotics
against A. baumannii. These investigators reported that ellagic and tannic acids at 40 µM,
increased the activity of novobiocin, coumermycin, chlorobiocin, rifampicin and fusidic acid
against A. baumannii. Likewise, Duarte et al. (2012) reported that the essential oil from coriander
exerted synergistic or additive effects with antibiotics such as tetracycline, chloroamphenicol,
ciprofloxacin, gentamicin, piperacillin and cefoperazone against A. baumannii. In addition, a
recent study by Saghi et al. (2015) reported that the essential oil from Origanum vulgare
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possessed potent antimicrobial activity against MDR A. baumannii. In yet another study,
Kollanoor-Johny et al. (2010) reported that sub-inhibitory concentrations of several PDAs,
including TC and EG decreased antibiotic resistance (P < 0.05) in MDR S. Typhimurium DT
104. Follow up mechanistic studies using RT-qPCR revealed that TC decreased antibiotic
resistance in DT 104 by down-regulating several antibiotic resistance genes.
In Gram-positive bacteria, Blanco et al. (2005) reported that epigallocatechin-gallate, an
ingredient in green tea, neutralized tetracycline resistance in Staphylococcus aureus by inhibiting
the efflux pump, TetK. Similarly, biacalein, a flavalone present in thyme extract potentiated the
effect of tetracyclines and β-lactams on methicillin-resistant S. aureus (Fujita et al., 2005). In
another study, two ingredients in the medicinal plant Berberis, namely berberine and 5’methoxyhydnocarpin, inhibited the multi-drug efflux pump, NorA in S. aureus (Sternmitz et al.,
2000). Likewise, TC was reported to reduce clindamycin resistance in the human pathogen,
Clostridium difficile (Shahverdi et al., 2007).
9. Summary
Being ubiquitous in distribution, A. baumannii has been isolated from soil, water and a
variety of foods, including fruits and vegetables, thereby raising concerns that fresh produce
could be a potential source of infection to humans, particularly in health-care settings. In
addition, the isolation of genotypically similar strains of Acinetobacter from food, environment
and clinical specimens further underscores the concerns on the role of food and water as
potential sources of human infections. Being resistant to most of the currently available
antibiotics, identification of effective antimicrobials or molecules that potentiate the efficacy of
antibiotics against A. baumannii is critical for controlling infections caused by this bacterium.

26

Based on published literature and preliminary research conducted in our laboratory, it
was hypothesized that MDR A. baumannii is potentially present on fresh vegetables, and
chlorine is ineffective as a water disinfectant forkilling the bacterium. In addition, it was
hypothesized that TC and EG reduce antibiotic resistance and virulence in A. baumannii, and
may be useful in treating wound infections caused by the bacterium.
The specific objectives of this dissertation were
1: To investigate the prevalence of MDR A. baumannii on fresh vegetables collected from
farmers’ market in Connecticut.
2: To determine the effect of chlorine on A. baumannii survival in water and expression of its
antibiotic resistance genes
3: To develop a real-time quantitative PCR for specific detection of A. baumannii in water and
blood.
4: To determine the effect of TC and EG on decreasing A. baumannii resistance to β-lactam
antibiotics.
5: To investigate the efficacy of TC and EG in reducing A. baumannii adhesion to and invasion
of human keratinocytes and controlling wound infections in vitro.
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Prevalence of MDR A. baumannii on fresh vegetables collected from farmers’ market in
Connecticut.
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ABSTRACT
This study determined the prevalence of multidrug resistant (MDR) A. baumannii on fresh
vegetables collected from farmers’ markets in Connecticut. One hundred samples each of fresh
carrots, potatoes and lettuce were collected during the period 2012-13 for one year. The
vegetables were sampled and streaked on selective media, namely Leeds Acinetobacter and
MDR Acinetobacter agars. All morphologically distinct colonies from MDR Acinetobacter agar
were identified using Gram staining, biochemical tests and polymerase chain reaction. In
addition, susceptibility of the isolates to ten commonly used antibiotics in humans, namely
imipenem, ceftriaxone, cefepime, minocycline, erythromycin, colistin-sulphate, streptomycin,
neomycin, doxycycline, rifampcin was determined using antibiotic disc diffusion assay. The
results revealed that out of 100 samples of each vegetable tested, only two samples of potato and
one sample of lettuce yielded A. baumannii. No carrot sample was found to be positive for A.
baumannii. However, several other opportunistic, MDR human pathogens such as Burkholderia
cepacia (1% potatoes, 5% carrots and none from lettuce), Stenotrophomonas maltophilia (6%
potatoes, 2% lettuce and none in carrots) and Pseudomonas luteola (9% potato, 3% carrot and
none in lettuce) were recovered from the vegetables. Antibiotic susceptibility screening of the
isolates revealed high resistance rates for ceftriaxone (100%), colistin-sulphate (83%),
erythromycin (83%) and streptomycin (66%) in B. cepacia; for colistin-sulphate (100 %) and
imipenem (90%) in P.luteola; for colistin-sulphate (100%), ceftriaxone (100%), cefepime (87%),
erythromycin (62%) and imipenem (50%) in S. maltophilia, and for imipenem (100%),
ceftriaxone (100%), erythromycin (100%) and streptomycin (100%) in A. baumannii. The results
revealed the presence of MDR bacteria, including human pathogens on fresh produce, thereby
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highlighting the potential health risk in consumers, especially those with a compromised immune
system.
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1. INTRODUCTION
Acinetobacter baumannii, a Gram-negative, aerobic, opportunistic bacterial pathogen,
which has emerged as one of the most problematic bacteria to treat due to its resistance to most
of the commonly used antibiotics (Fishbain and Peleg. 2010;Moradi et al., 2015). A. baumannii
has been reported as the most common multi-drug resistant (MDR) pathogenic bacterium
involved in hospital-acquired infections, particularly intensive care units (Dijkshoorn et al.,
2007; Marti et al., 2011) causing mortality rates ranging from 34 to 61% (Esterly et al., 2011). In
addition, A. baumannii is capable of causing a wide spectrum of infections in humans, including
ventilator associated pneumonia, bacteremia and meningitis (Joshi et al., 2006; Maragakis and
Perl; 2008; Manchanda et al., 2010; Guner et al., 2011; Solak et al., 2011). Acinetobacter spp.
isfrequently isolated from soil and water (Baumann, 1968; Warskow and Juni, 1972; Eliopoulos,
2008; Krizova, 2014), which are considered to be their major habitats. Acinetobacter was
reported to be present at a level of 38% in ground water samples (Bifulco et al., 1989), with
isolation from water systems in multiple parts of the world (Ferreira et al., 2011; Zhang et al.,
2013). Moreover, protozoans such as Acanthamoeba were found to support the growth of A.
baumannii, and act as its reservoir in water (Cateau et al., 2011). In addition, Acinetobacter spp.,
including A. baumannii, have been isolated from other sources such as foods, arthropods,
animals and humans (Baumann, 1968; Berlau et al., 1999; Mussi et al., 2005; Fournier and
Richet, 2006; Munoz-Price and Weinstein, 2008). Although a few investigations conducted
overseas have isolated A. baumannii and other Acinetobacter spp. from a variety of fresh
produce, no extensive studies have been undertaken in the United States.
During the last decade, there has been an increased in the demand for local and regional
food products, especially fresh produce because of their perceived freshness and quality, which

50

is believed to be due to a shorter period of time elapsed between harvesting and selling.
According to the USDA’s Agricultural Marketing Service, there has been a rise in the number
and popularity of farmers’ markets over the years in the United States, with an increase in
number from 1,755 in 1994 to 8,284 in 2014 (USDA-ERS, 2014). However, relatively scant
information exists on the microbiological safety and quality of fresh produce sold at farmers’
markets as against retail sold produce. In addition, concerns exist about the storage conditions of
the produce displayed throughout the day, the farming practices adopted by the farmers, and the
pre- and post-harvest handling techniques employed (Kader and Rolle, 2004). A study conducted
on the microbiological safety and quality of herbs sold at farmers’ markets in Los Angeles,
Orange county and Seattle revealed the presence of Salmonella and generic Escherichia coli,
although the sources and extent of contamination were not reported (Levy et al., 2014). Another
study compared the microbial populations in lettuce and spinach obtained from grocery stores
and farmers’ markets in Indiana, and reported greater bacterial (mesophilic plate count), yeast
and mold contamination on lettuce from farmers’ markets (Soendjojo, 2012). A study conducted
in Germany revealed that vegetables from farmers’ markets contained more antibiotic resistance
bacteria when compared to those sold at retail stores (Schwaiger et al., 2011). The same
researchers suggested that since vegetables from farmers’ markets are not usually cooled or
washed with antimicrobials, the bacteria present have greater chances of carrying and expressing
antibiotic resistance genes (Schwaiger et al., 2011) as exposure of bacteria to stresses such as
low temperature was found to lower the MIC of antimicrobials as compared to unstressed
controls (McMahon et al., 2007). In a recent study conducted in British Columbia, Canada,
Wood et al. (2015) tested lettuce (n = 68) collected from five farmers’ markets, and found that
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13% of the samples contained E. coli, and 97% of the E. coli isolates displayed resistance to one
or more antimicrobials.
The objective of this study was to determine the prevalence of MDR A. baumannii in
fresh vegetables, specifically carrots, lettuce and potatoes collected from farmers’ markets in
Connecticut.
2. MATERIALS AND METHODS
2.1. Sample collection and detection of Acinetobacter spp.
The prevalence rate of A. baumannii in vegetables reported in the literature ranges from 17%
(Berlau et al., 1999) to 50% (Houang et al., 2001). Based on a conservative 5% prevalence rate,
we conducted a power analysis using the probability theory (Snedecor and Cochran, 1967) to
determine the number of vegetable samples required for isolating A. baumannii with a
confidence level of 95%. Based on the power analysis results, a total of 100 samples each of
fresh potatoes, carrots and lettuce were procured from 55 farms distributed over 15 farmers’
markets in various counties in Connecticut. All the vegetables were sold loose and unprocessed,
and were randomly purchased from different vegetable stands. All samples were immediately
brought to the laboratory on ice, and processed within 8 h of collection. The sample collection
was made during the period 2012-13 for one year covering two successive cropping seasons. For
the detection of A. baumannii, approximately fifty grams of each sample was shaken vigorously
in 450 ml sterile Tryptic soy broth (TSB) in a Whirlpak bag (Nasco, Fort Atkinson, WI) for 2
min. The samples were then streaked on selective media, namely Leeds Acinetobacter medium
and MDR Acinetobacter medium (Hardy Diagnostics, Santa Maria, CA), which have been used
to isolate Acinetobacter spp. from both clinical and environmental samples (Jawad et al., 1994).
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In addition, the enrichment samples in TSB were incubated at 37oC for 24 h and streaked again
on Leeds and MDR Acinetobacter media. The plates were incubated at 37oC for 24 h.
2.2. Identification and Characterization of the Isolates
All morphologically different colonies from MDR Acinetobacter medium were first subjected to
Gram staining, followed by presumptive identification by biochemical tests using API 20 NE
(bioMérieux, Cambridge, MA), which assays for 61 Gram-negative bacteria (Chang et al., 2005;
Bosshard et al., 2006; Dortet et al., 2006). The manufacturers’ instructions were followed for
performing the biochemical tests. Each biochemical test well was inoculated with an overnight
(0.5 McFarland) bacterial suspension, followed by incubation at 37oC. The tests results were read
after 24 and 48 h, and the interpretation of the results was done using the identification software
version 6.0 (bioMérieux, Cambridge, MA). All the cultures were also subjected to oxidase test to
compliment the biochemical tests in API 20 NE. Following identification by biochemical tests,
the isolates were further confirmed by polymerase chain reaction (PCR) using 16s rRNA
(Widmer et al., 1998; Clode et al., 1999; LiPuma et al., 1999; Whitby et al., 2000). The
chromosomal DNA from each isolateextracted using InstaGene Matix (Bio-Rad, Hercules, CA)
was used as a template for PCR. The primers tested for confirming the isolates are provided in
Table1. The amplification of the 16S ribosomal RNA in each sample was performed in a
thermocycler (PTC 100; MJ Research, Waltham, MA). PCR conditions were initial denaturation
at 95oC for 5 min, followed by 40 cycles of denaturation at 94oC for 1 min, annealing at 55-62oC
(depending on the target bacteria) for 30 s and extension at 72oC for 10 min. The resulting PCR
amplicons were examined by gel electrophoresis and visualization by gel documentation system
(Bio-Rad, Hercules, CA).
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2.3. Antibiotic Susceptibility Testing
The susceptibility of the various isolates to 10 antibiotics was tested by disc diffusion
method (NCCLS, 1999). The antibiotics screened included Imipenem (10 μg), Ceftriaxone (30
μg), Cefepime (30 μg), Minocycline (30 μg), Erythromycin (15 μg), Colistin-sulphate (10 μg),
Streptomycin (10 μg), Neomycin (30 μg), Doxycycline (30 μg), Rifampcin (5 μg) purchased
from Oxoid (Hampshire, UK). All the cultures were incubated at 37oC for 24 h. The zone
diameter around the discs was measured horizontally and vertically.
3. RESULTS AND DISCUSSION
Fresh produce constitutes the leading cause of foodborne illnesses when compared to
other food products (Doyle and Erickson, 2008), and a report from the US Centers for Disease
Control and Prevention indicated that ~ 46% of all foodborne illnesses are caused by
contaminated produce (Painter et al., 2013). Several pre-harvest factors such as proximity or
contact with soil, feces, use of improperly composted manure, contaminated irrigation water,
wild and domestic carrier animals and farm workers potentially contribute to contamination of
fresh produce with a variety of microorganisms (Beuchat, 1996; Beuchat and Scouten, 2002).
Antibiotic usage in food animal production, and simultaneous presence of antibiotic resistant
bacteria in manure leads to potential persistence of these bacteria in agricultural soil (Sarmah et
al., 2006). Since microorganisms present in soil could be transferred to produce, fresh produce
consumption is reported as a potential route of direct human exposure to soil bacteria (Marti et
al., 2013). In addition, usage of antibiotics in plant agriculture and contamination of irrigation
water with animal feces could also serve as potential sources of antibiotic resistant bacteriaon
fresh produce (Holvoet et al., 2013). The presence of antibiotic resistant bacteria on fresh
produce is a significant concern to public health because of the potential transfer of antibiotic
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resistance determinants to the enteric flora in humans (Sommer et al., 2010; Schjorring and
Krogfelt, 2011). Similarly, Falomir et al. (2010) indicated that the presence of antibiotic
resistance determinants in normal flora and pathogenic microorganisms on fresh vegetables
might contribute to horizontal spread of resistances between different isolates, species and
genera. It was also suggested that antibiotic resistance genes on transferable elements such as
plasmids facilitates rapid distribution of resistance determinants among bacteria (De la Cruz and
Davies, 2000; Heuer and Smalla, 2007). Thus monitoring the prevalence of antibiotic resistant
bacteria on fresh produce is critical for risk assessment and devising appropriate food safety
interventions.
In this study, we determined the prevalence of MDR A. baumannii on fresh vegetables
such as lettuce, carrots and potatoes, which are previously reported to harbor A. baumannii
(Berlau et al., 1999; Falomir et al., 2010). All 100 samples each of potatoes, carrots and lettuce
were found to yield colonies on Leeds Acinetobacter medium. In addition, 74% potatoes, 86% of
carrots, 73% lettuce samples had colonies growing on MDR Acinetobacter agar. These isolates
were characterized using API 20 NE biochemical tests and confirmed with PCR using specific
16s rRNA primers. As observed in Table 2, out of the 100 samples of each vegetable tested, only
two samples of potato and one sample of lettuce were found to be positive for A. baumannii. No
carrot sample was positive for the pathogen. Previously, Berlau and colleagues (1999), while
studying the prevalence of Acinetobacter in fresh produce in the United Kingdom, reported that
17% of 177 samples tested positive for the bacteria, including A baumannii. These investigators
observed that 56% of the Acinetobacter belonged to A.baumannii-A. calcoaceticus group, which
were found on apple, melon, bean, cabbage, cauliflower, carrot, potato, radish, lettuce,
cucumber, pepper, mushroom, and sweet corn. In another study, Houang et al. (2001) isolated A.
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baumannii and genomospecies 3 from 21 of 41 vegetable samples, 53 of 74 fish and meat
samples and 22 of 60 soil samples. Similarly, Falomir et al. (2010) detected the presence of A.
baumannii on fresh lettuce collected from a nursery in Valencia city, Spain, with a most probable
number of >2400, where the bacterium was found to exhibit resistance to four different
antibiotics, namely amoxicillin/clavulanic, ampicillin, chloramphenicol and nitrofurantoine. In
yet another study, Walia et al. (2013) reported the isolation of A. baumannii along with other
Gram negative bacteria from ready-to-eat baby spinach collected from local retail supermarkets
in Rochester, MI. The isolates showed maximum resistance to cefoxitin, ampicillin,
chloramphenicol, ceftrizoxime and tetracycline (Walia et al., 2013). Moreover, the resistance
was found to be transferable in the strains tested.(Walia et al., 2013).
Although, this study was intended to focus on A. baumannii, several other antibiotic
resistant bacteria were isolated from the MDR Acinetobacter agar plates besides A. baumannii.
The major bacteria isolated included Burkholderia cepacia, Stenotrophomonas maltophilia and
Pseudomonas luteola. Although no lettuce samples tested positive for Burkhoderia, 1% of
potatoes and 5% of carrots yielded B. cepacia. B. cepacia is a plant pathogen causing soft rot of
onions (Govan et al., 1996); however, it is now considered an opportunistic human pathogen
causing respiratory and urinary tract infections as well as bacteremia in humans (Hutchinson et
al., 2004; Mahenthiralingam et al., 2008). In addition, 6% of potatoes and 2% of lettuce tested
were found to harbor S. maltophilia. S. maltophilia is ubiquitously present in the environment,
and is commonly found associated with the rhizosphere of plants such as potato, wheat and
cucumber (Muder et al., 1996; Denton et al., 1998; Berg et al., 1999); however, the bacterium is
increasingly recognized as a nosocomial and opportunistic pathogen in humans (Senol, 2004;
Tan et al., 2008; Brooke, 2012), especially with intrinsic resistance to many broad spectrum
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antibiotics (Clark et al.,2003; Wang et al.,2004; Meyer et al.,2006). In a study conducted by Berg
et al. (1999), several isolates of S. maltophilia from rhizospheres of plants exhibited resistance to
multiple antibiotics, including Imipenem. In the current study, we also isolated P. luteola in 9%
of potatoes and 3% of carrots, with no lettuce samples testing positive for this pathogen. P.
luteola, formerly Chryseomonas luteola, is a saprophyte and psychrotrophic bacterium that can
be isolated from water, soil, damp environments and vegetables (Membre and Kubaczka, 1998;
Doublet et al., 2010). It is considered a rare pathogen, but is known to cause septicemia,
meningitis and infections in humans, which are mainly attributed to the use of contaminated
catheters and prostheses (Doublet et al., 2010).
All of the aforementioned bacterial isolates were screened for resistance to ten antibiotics,
which included two drugs from five major classes of antibiotics commonly used in human
medicine (Tice et al., 2004; Karageorgopoulos and Falagas, 2008). The antibiotic resistance
profile of the aforementioned isolates is depicted in Table 3. All the isolates of A. baumannii
were resistant to Imipenem (100%), Ceftriaxone (100%), Erythromycin (100%) and
Streptomycin (100%); two of the isolates were resistant to Cefepime, Neomycin and
Doxycycline, and one isolate showed resistance to Minocycline, Colistin-sulphate and
Rifampcin. It is important to note that although the prevalence of A. baumannii on the vegetables
was low, the isolates were highly resistant to the commonly used antibiotics such asImipenem,
Ceftriaxone, Erythromycin and Streptomycin. In a previous study conducted by Falomir et al.
(2010), A. baumannii isolated from vegetables were resistant to Amoxicillin/clavulanic,
Ampicillin, Chloramphenicol and Nitrofurantoine. Similarly, all B. cepacia/ isolates were
resistant to Ceftriaxone, and five isolates were resistant to Cefepime, Colistin-sulfate and
Erythromycin. The isolates showed least or no resistance to Doxycycline, Neomycin and
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Minocycline. While all the isolates of S. maltophilia showed resistance to Colistin-sulfate and
Ceftriaxone, they were susceptible to Minocycline and Doxycycline. P. luteola isolates showed
maximum resistance to Colistin-sulfate and Imipenem and least resistance to Doxycycline and
Minocycline.
To conclude, while results of this study indicate a low prevalence of MDR A. baumannii
on vegetables, the presence of other opportunistic, MDR pathogens represents a potential health
hazard to consumers, especially for immune-compromised and convalescent people. It is also
critical to note that the isolates possessed resistance to common clinically used antibiotics in
humans. Although risk assessment studies on human exposure to antibiotic resistant
bacteria through the consumption of meat (via undercooking or cross-contamination) are
available (Presi et al., 2009; Depoorter et al., 2012), such information on fresh produce is sparse.
Moreover, since majorities of fresh produce are generally consumed without being subjected to a
terminal microbial killing step unlike animal food products, the potential risk for human
exposure to antibiotic resistant bacteria is greater, thereby underscoring the significance of good
agricultural practices in farming.
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Table 1. List of primers used in confirming bacteria isolated from vegetables from Farmers
markets
Bacteria
A. baumannii

Primer sequence
Size (bp)
AB-R
GACGATCTGTAGCGGGTCTG
712
AB-F
CCAGGTAAGGTTCTTCGCGT
Burkholderiaa RHG-F GGG ATT CAT TTC CTT AGT AAC
494
RHG-R GCG ATT ACT AGC CAT TCC AGA
B. cepaciab
PSR1
TTT CGA GCA CTC CCG CCT CTC AG
209
PSL1
AAC TAG TTG TTG GGG ATT CAT TTC
Pseudomonasc PS-for GGT CTG AGA GGA TGA TCA GT
990
PS-rev TTA GCT CCA CCT CGC GGC
c
P. luteola
PL- F
AGA TGG ATT GGT GCC TTC GG
304
PL-R
CAG ACT GCG ATC CGG ACT AC
S. maltophiliad SM4
TTA AGC TTG CCA CGA ACA G
532
SM1
CAG CCT GCG AAA AGT A
a
LiPuma et al.,1999;; bClode et al., 1999; c Widmer et al., 1998; dWhitby et al., 2000
Table 2. Prevalence of multi-drug resistant bacteria in vegetables from farmers’ markets in
Connecticut
Vegetable
Potato(n = 100)
Carrot(n=100)
(n=100)
Lettuce
(n=100)
(n=100)
Total
(n=100)

A.baumannii
2
0
1
3

B.cepacia
1
5
0
6

S.maltophilia
6
0
2
8

P. luteola
9
3
0
11

Table 3. Antibiotic resistance profile of the isolates from vegetables
Antibiotics
tested
Imipenem
Ceftriaxone
(10 mcg)
Cefepime
(30
mcg)
Minocycline
(30 mcg)
Doxycycline
(30 mcg)
Colistin-sulfate
(30
mcg)
Streptomycin
(10 mcg)
Neomycin
(10
mcg)
Erythromycin
(30 mcg)
Rifampcin
(15 mcg)
(5 mcg

A.baumannii
Resistant
isolates(%)
100
100
66
33
66
33
100
66
100
33

B.cepacia
Resistant
isolates(%)
33
100
83
0
16
83
66
16
83
33

S.maltophilia
Resistant
isolates(%)
50
100
87
0
0
100
50
25
62
37

P.luteolaResista
nt isolates(%)
90
82
63
27
9
100
54
27.
63
36
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Chapter IV

Effect of chlorine on A. baumannii survival in water and expression of antibiotic resistance
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ABSTRACT

Acinetobacter baumannii is a multi-drug resistant pathogen capable of causing a wide spectrum
of clinical conditions in humans. Being ubiquitous in distribution, Acinetobacter spp. has been
found in surface water, ground water, natural spring water and drinking water, thereby
underscoring the significance of water disinfection to control human infections. Chlorine is the
most commonly used disinfectant in drinking and recreational water. Federal agencies, the CDC
and EPA, recommend a maximum free chlorine level of 4 ppm in drinking water and 3 ppm in
swimming water. This study investigated the effect of different levels of chlorine on the
survivability of A. baumannii in water. Additionally, the effect of chlorine exposure on the
transcription of genes conferring antibiotic resistance in A. baumannii was studied. Eight clinical
isolates of A. baumannii, including a fatal meningitis isolate (ATCC 17978) at ~108 CFU/ml
were separately exposed to different chlorine concentrations (0.2, 1, 2, 3 and 4 ppm) with a
contact time of 30, 60, 90 and 120 sec. The surviving pathogen counts at each specified contact
time were determined using broth dilution assay. In addition, real-time quantitative PCR (RTqPCR) analysis of the antibiotic resistance genes namely efflux pump genes (adeA, adeB, adeC,
abeM), and those that code for resistance to antibiotics such as β-lactams (blaP), aminoglycoside
(ami), sulfamethoxazole (sul1), tetracycline (tetA), and multiple drug resistance protein (mdrp),
of three selected A. baumannii strains following exposure to chlorine was performed. Results
revealed that all eight A. baumannii isolates survived the tested chlorine levels during all
exposure times (P> 0.05). The RT-qPCR analysis revealed an up-regulation of all or some of the
antibiotic resistance genes in the isolates, indicating a chlorine-associated induction of antibiotic
resistance in the pathogen. Our results reveal that chlorine is not only ineffective in reducing A.
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baumannii in water, but also induces the up-regulation of genes conferring resistance to multiple
antibiotics in the pathogen.
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1. INTRODUCTION
Multi-drug resistant (MDR) Acinetobacter baumannii is a major hospital-borne pathogen
causing a wide spectrum of clinical conditions with significant mortality rates (Dijkshoorn et al.,
2007; Giamarellou., 2010; Perez et al., 2007; Karageorgopoulos et al.,2008; Peleg et al.,
2008;Martí, 2011).A. baumannii strains are equipped with a multitude of antibiotic resistance
mechanisms rendering them resistant to most of the currently available antibiotics (Dijkshoorn et
al., 2007; Karageorgopoulos et al.,2008). A. baumannii has a remarkable ability to persist for
prolonged periods of time in the hospital environment in biofilms, thereby protecting it from the
action of disinfectants, and serving as a continuous source of infection (Urban et al., 2003;
Gaddy et al.,2009; Shin et al.,2009; Moultrie et al., 2011; Pour et al., 2011). In health-care
environments, a variety of surfaces, including table tops, bed rails, sinks, door handles, floors,
mattresses, and pillows have been implicated as potential sources of A. baumannii(Wilks et
al.,2006; Karageorgopoulos et al., 2008;).
Water and soil are considered as a major habitat ofA. baumannii, although the pathogen
has been isolated from other sources, including foods, anthropods, animals, and humans
(Baumann et al., 1968; Berlau et al., 1999; Mussi et al., 2005; Fournier et al., 2006; Munoz-Price
et al., 2008). Moreover, protozoans such as Acanthamoeba have been reported to support the
growth of A. baumannii, and act as itsreservoir in water (Cateau et al., 2011). Recently, alarming
reports indicating the potential presence of A. baumannii in water systems have been reported
from several parts of the world (Ferreira et al., 2011; Zhang et al., 2013). The ability of A.
baumannii to thrive in water may result in fatal infections in all age groups (Kempf et al., 2012).
Chlorine has long been used as a disinfectant in drinking water and in swimming pools to
inactivatepathogenic microorganisms, thereby making the water safe for human use (Ngwenya et
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al, 2013; Shrivastava et al., 2004; WHO, 1993). In the United States, the Environmental
Protection Agency (EPA) recommends a maximum free chlorine level of 4 ppm in drinking
water (EPA, 2012). In addition to the standards described for chlorine in drinking water, the
Centers for Disease Control and Prevention (CDC) have recommended 1-3 ppm chlorine in
swimming pool water for recreational purposes (CDC, 2012). However, a variety of
microorganisms have been recovered from drinking water distribution systems that maintained
chlorine levels between 0.5 – 1.0 ppm, indicating that the low levels of chlorine may not
inactivate harmful microorganisms (Means et al., 1981; Ridgway et al., 1982; LeChevallier et al.,
1984). It is also reported that chlorine used in potable water can selectively promote the survival
of antibiotic resistant bacteria (Armstrong et al., 1981; 1982; Murray et al., 1984; Shrivastava et
al., 2004). For instance, drinking water with suboptimal levels of chlorine selectively promoted
the survivalof multidrug resistant Pseudomonas aeruginosa (Shrivastava et al., 2004).
Since A. baumannii could potentially contaminate drinking or recreational water, and that
chlorine at the recommended levels may not be effective in killing the pathogen, the current
research investigated the viability of A. baumannii in water containing chlorine at the
recommended levels for potable and recreational usage. In addition, the effect of chlorine
exposure on various antibiotic resistance genes in the pathogen was investigated.
2.

MATERIALS AND METHODS

2.1. A. baumannii Strains and Growth Conditions
Eight strains of A. baumannii, including 251847, 134882, 173795, 474030, 190451,
163731, and 251352 kindly gifted by the International Health Management Associates (IHMA,
City, State), and ATCC 17978 (fatal meningitis isolate) were used in the chlorine survival study.
The antibiotic resistance profile of the seven clinical strains was Amikacin (MIC 64 μg/mL),
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Amoxicillin (MIC 32 μg/mL), Cefepime (MIC 32 μg/mL), Ceftazidime (MIC 32 μg/mL),
Ceftriaxone (MIC 64 μg/mL), Imipenem (MIC 4–32 μg/mL), Levofloxacin (MIC 8 μg/mL),
Meropenem (MIC 16 μg/mL), Minocycline (MIC 1–16 μg/mL), and Piperacillin (MIC 128
μg/mL).
Each strain of A. baumannii was grown individually on MDR Acinetobacter and Leeds
Acinetobacter agars (Hardy Diagnostics, Santa Maria, CA), and an individual colony from these
media was subcultured at least 3 times in tryptic soy broth (TSB; Difco) for 24 h at 37 oC with
shaking (200 rpm). After the subcultures, the bacterial cells were harvested from an overnight
culture by centrifugation at 3600 x g for 30 min at 4oC. The cells were washed twice in sterile
phosphate buffered saline (PBS, pH=7.2), and the bacterial cell pellet was finally resuspended in
PBS to get a final concentration of 109 cfu/ml. The bacterial population in the inoculum was
confirmed by broth dilution and surface plating on tryptic soy agar (TSA; Difco) plates.
2.2. A. baumannii Survival Assay
The effect of chlorine on A. baumannii viability in water was determined using a published
protocol (Zhao et al., 2001). Deionized, non-chlorinated (EMD Millipore, Billerica, MA) water
was used for the study. For each experiment, different chlorine concentrations (0.2, 1, 2, 3 and 4
ppm) in water were achieved by adding standard chlorine solution (Aqua solutions, Deer Park,
Texas) to pre-sterilized deionized water. The final concentration of free chlorine in water was
confirmed using a digital titrator (Pocket colorimeterTMII, Hach, City, State). One ml of A.
baumannii suspension containing 109 cfu/ml was added to 99 ml of the sterile deionized water
containing chlorine at the specifiedconcentrations in a 200 ml Erlenmeyer flask. After thorough
mixing, 0.5 ml samplesweretaken at 30, 60, 90 and 120 s, and transferred to 4.5 ml neutralizing
broth for buffering chlorine (NB, Difco). Serial ten-fold dilutions in PBS were made and 0.1 ml
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of each dilution was surface plated on duplicate on TSA. The plates were incubated at 37oC for
24 h. After enumeration of the colonies, the counts were expressed as log10 cfu/ml. The colonies
on TSA were confirmed as A. baumannii by streaking on MDR and Leeds agar plates. Each
experiment was done in duplicates and the experiment replicated three times.
2.3. Antibiotic Resistance Gene Expression
2.3.1. RNA Isolation and cDNA Synthesis
Three selected strains of A. baumannii (ATCC 17978, 251847 and 474030) were grown on
MDR plates and subcultured in TSB separately at 37oC as before. The bacterial populations in
the cultures were confirmed to contain ~8 log10 CFU/ml by plating appropriate dilutions on TSA.
The overnight culture from the tubes was centrifuged, washed twice, and reconstituted in PBS as
described before. One ml each of this reconstituted culture was transferred to two sets of tubes
containing 9 ml of sterile deionized water. To one set of tubes, chlorine was added to yield a
concentration of 2 ppm in water. The other set of tubes served as non-chlorine control. The 2
ppm concentration was chosen for the RT-qPCR analysis since the United States Department of
Health (USDH) recommends the free chlorine concentration of 1 and 3 ppm to disinfect
swimming pools (CDC, 2012). Both set of tubes were incubated at 25oC for 15 min. The
bacterial culture from each tube was centrifuged at 12,000 x g for 2 min at 4oC. The supernatant
was discarded and the pellet was added with 0.5 ml of sterile water and 1 ml of RNA protect
reagent (Qiagen, Valencia, CA). The mixture was then incubated at 25oCfor 5 min. The RNeasy
mini kit (Qiagen) was used for extracting total RNA from the control and chlorine-treated
samples. The RNA was quantified using Nanodrop (Biorad) by measuring the absorbance at 260
and 280 nm. Super-script II reverse transcriptase kit (Invitrogen, Carlsbad, CA) was used for
cDNA synthesis from the extracted RNA.
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2.3.2. Real-Time quantitative PCR (RT-qPCR)
The following A. baumannii genes were used for the gene expression analysis: efflux
pump genes adeA, adeB, adeC, and abeM; chloramphenicol resistance gene, cmr, β-lactam
resistance gene, blaP; sulphonamide resistance gene sul1; tetracycline resistance gene, tetA, and
multidrug resistance protein, mdrp.
The primers specific for the genes and for the endogenous control (16SrRNA) were
designed using the Primer Express software® (Applied Biosystems, Foster City, CA, USA based
on Acinetobacter baumannii AB0057 genome (CP001182.1) published in the NCBI database
(Adams et al., 2008). The primers used in the study are provided in Table 1. Custom synthesized
primers for each gene were obtained from Integrated DNA Technologies (Foster City, CA USA).
RT-qPCR was done with the ABI Prism 7900 sequence detection system (Applied Biosystems)
using the SYBR green assay under custom thermal cycling conditions with the normalized
mRNA as template (Kollanoor-Johny et al., 2012). The samples were analyzed in duplicates and
standardized against 16S rRNA gene expression. The relative changes in mRNA expression
levels were determined using comparative threshold cycle (CT) method (2-CT) between the
chlorine-exposed and chlorine non-exposed A. baumannii.
2.4. Statistical Analysis
The counts of A. baumannii in the control and treated samples were logarithmically
transformed (log10 cfu/ml) to aid in statistical analysis. Since there was no significant difference
in bacterial counts between the strains following exposure to chlorine treatment, the data from
the eight strains were pooled and averaged. Data analysis was done using the PROC-MIXED
procedure of statistical analysis software (SAS version 9.2; SAS Institute Inc., Cary, NC, USA).
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Fisher’s least significance test (LSD) was used to determine the differences between the means at
a P level of  0.05.
3. RESULTS AND DISCUSSION
In order to determine if A. baumannii survived the recommended levels of chlorine, we
determined the survival of the pathogen exposed to 0 to 4 ppm of free chlorine for 30, 60, 90 and
120 seconds in deionized water (Table 2). All the eight A. baumannii controls, where no chlorine
was added had 107 CFU/ml bacteria at all the time points tested. When exposed to free chlorine
levels ranging from 0.2 to 4 ppm, all the eight strains of A. baumannii survived with no
significant decrease in their counts throughout the sampling period (P> 0.05).
Chlorine is generally used to disinfect both potable and recreational water with
stipulated standards for inclusion as determined by the EPA, FDA and CDC. However, previous
studies have indicated that chlorine was not completely effective in inactivating several
pathogenic bacteria. For example, Yersinia enterocolitica, Yersinia pestis, Pasteurella multocida
and Hafnia alvei were isolated from chlorine treated sewage water, indicating the inefficiency of
chlorine in killing these pathogens (Murray et al., 1984). In another study, Zhao et al. (2001)
reported an isolate of E.coli O157:H7 showing tolerance of up to 2-ppm free chlorine treatment
after one minute exposure, among six other isolates tested in their study. In yet another study, E.
coli isolated from a chlorine treated swimming pool were found to be resistant to chlorine for up
to 9 passages (Farkas-Himsley, 1964). High tolerance of bacteria to disinfectants could either be
intrinsic or resulting from mutation. Additionally, wide spread use of disinfectants has been
reported to trigger the selection of resistant strains (McDonnell et al., 1999).
Since we observed that A. baumannii could survive all the tested concentrations of
chlorine in water, we investigated the effect of chlorine exposure on major antibiotic resistance
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determinants using RT-qPCR.The effect of chlorine exposure on the expression of ten major
antibiotic resistance genes conferring resistance to multiple antibiotics in A. baumannii was
studied in ATCC strain 17978, 251847, and 474030. The ATCC strain was selected since it has
been widely studied, and was isolated from a 4-month-old infant who died of fatal meningitis
resulting from an acute infection. The results on the effect of chlorine exposure on antibiotic
resistance genes in theATCC strain are shown in Figure 1. Among the various genes tested, those
controlling antibiotic efflux pumps in A. baumannii, namely adeA, adeB, and abeM were
significantly up-regulated by more than six folds when compared to the control, while the efflux
pump gene, adeC and the gene encoding chloramphenicol resistance,cmr were up-regulated by
about four folds (P< 0.05). A three fold up-regulation was noticed in blaP that confers resistance
to β lactam group of antibiotics upon exposure to chlorine (P> 0.05). Exposure to chlorine also
resulted in an increase in the expression of aminoglycoside (ami) and sulphonamide (sul1)
resistance genes by three and four folds, respectively (P<0.05). In addition, an eight-fold upregulation (P< 0.05) of the gene encoding multiple drug resistance protein (mdrp) in A.
baumannii was observed following exposure to chlorine. However, no significant change in the
expression of tetracyclineresistance encoding gene, tetA was observed upon exposure to chlorine
(P> 0.05). The results revealed that the efflux pump genes were more up-regulated compared to
the antibiotic resistance genes (Figure 1), highlighting the involvement of efflux pump
mechanisms on rapid exposure to chlorine (Xi et al., 2009). Figure 2 shows the antibiotic gene
expression in A. baumannii 251847, where a significant up-regulation was observed in the
expression of adeC, cmr and tetA by nine, four and five folds, respectively (P< 0.05). However,
the expression of all the other genes tested was decreased following chlorine exposure (P< 0.05).
In A. baumannii 470430, a significant up-expression of all genes except tetA (Figure 3) was
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observed after exposure to chlorine (P< 0.05), which was similar to trend observed in the ATCC
isolate. To summarize, despite variations in the expression levels of specific genes, exposure to
chlorine induced the expression of multiple antibiotic resistance genes in all the three isolates of
A. baumannii studied.
Although preventative chlorine levels are in use, several reports suggest that chlorine at
suboptimal levels could induce the expression of critical genes in pathogenic bacteria. Shi and
coworkers reported that chlorine enhanced the expression of antibiotic resistance genes in
diverse microbial populations isolated from drinking water (Shi et al., 2013). Similarly, an
increase in the expression of several antibiotic resistance genes was noted in E.coli and P.
aeruginosa by other research groups (Shrivastava et al., 2004; Krige, 2009). It was observed that
exposure to chlorine induced stress tolerance in bacteria making them more resistant to
antibiotics (Armstrong et al., 1981; 1982). It is also reported that chlorine exposure could induce
over expression of efflux pumps resulting in the pumping out of disinfectants and antibiotics by
bacteria (Xi et al., 2009).
In conclusion, the current investigation indicated that free chlorine concentration of up to 4
ppm was not effective in killing multidrug resistant A. baumannii isolates. All A. baumannii
isolates were able to survive the recommended levels of chlorine in water. Further, chlorine
exposure was found to increase the expression of efflux pumps and genes conferring resistance
to chloramphenicol, sulphonamides, and beta-lactam group of antibiotics. Further studies are
required to understand the mechanism behind chlorine-induced gene expression in A. baumannii,
and its significance to public health.
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Table 1: List of primers used in determing the effect of chlorine on antibiotic resistance genes in
A. baumannii
Gene
16S-rRNA (F)
(R)
adeA (F)
(R)
adeB (F)
(R)
adeC (F)
(R)
adeM (F)
(R)
blaP (F)
(R)
cmr (F)
(R)
ami (F)
(R)
sul1 (F)
(R)
tetA (F)
(R)
mdrp(F)
(R)
(F), forward; (R), reverse

Sequence (5’ 3’)
TCGCTAGTAATCGCGGCATCACGCTGGCGGC
GACGGGCGGTGTGTACAAG
TGACCGACCAATGCACCTT
GCAACAGTTCGAGCGCCTAT
CCGATGACGTATCGAAGTTAGGA
CCGATGACGTATCGAAGTTAGGA
ACGGCCCCAGAAGTCTAGTTC
CGATTAACCCCAATAACCCAGTT
GGTACATGGAAGCCCAGTTCTT
CCACTTTCTCTTGCCATTGCT
ACACTAGGAGAAGCCATGAAGCTT
GCATGAGATCAAGACCGATACG
CTATTTGAATTTGCGGTTTATATTGG
TGCACTTACACCGAAATCTTCAG
TGATCCCGTAAATGAGTTGAATTG
GCGGGCAAATGTGATGGTA
GGCATGACAATAGGGCAGTTG
CCAAAAAGTAGATGATAATACCGGTAAA
CTGCGCGATCTGGTTCACT
GCATACAGCGCCAGCAGAA
GTACGGCTTCTAGACCCACCAT
ACAAAGAGCCGTGCACAGTTT
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Table 2. Effect of chlorine concentrations on the survival of A. baumannii in deionized water*
Chlorine(ppm)

0

Isolates

ATCC
251847
134882
173795
474030
190451
163731
251352
0.2
ATCC
251847
17978
134882
173795
474030
190451
163731
251352
1
ATCC
251847
17978
134882
173795
474030
190451
163731
251352
2
ATCC
251847
17978
134882
173795
474030
190451
163731
251352
 Non significant at P> 0.05

A. baumannii (log10 CFU/ml)
30 sec

60 sec

90 sec

120 sec

7.38±0.07
7.29±0.03
7.58±0.07
7.34±0.09
7.32±0.09
7.52±0.06
7.48±0.07
6.8±0.14
7.42±0.13
7.33±0.07
7.53±0.06
7.21±0.07
7.31±0.09
7.58±0.09
7.45±0.1
7.15±0.03
7.34±0.1
7.27±0.07
7.3±0.06
7.22±0.15
7.31±0.07
7.71±0.03
7.53±0.06
7.13±0.03
7.45±0.05
7.14±0.02
7.44±0.08
7.62±0.08
7.39±0.16
7.64±0.08
7.43±0.13
6.06±0.08

7.42±0.06
7.33±0.1
7.56±0.06
7.38±0.09
7.37±0.12
7.63±0.07
7.48±0.04
6.86±0.18
7.44±0.09
7.27±0.08
7.54±0.05
7.15±0.03
7.33±0.1
7.65±0.1
7.55±0.09
7.19±0.05
7.39±0.09
7.24±0.09
7.33±0.05
7.09±0.01
7.37±0.11
7.66±0.04
7.48±0.06
7.14±0.04
7.42±0.05
7.17±0.05
7.41±0.09
7.64±0.08
7.43±0.12
7.66±0.05
7.43±0.1
6.03±0.05

7.41±0.06
7.28±0.04
7.58±0.05
7.35±0.1
7.37±0.11
7.64±0.05
7.49±0.09
6.8±0.15
7.45±0.1
7.28±0.07
7.46±0.05
7.09±0.02
7.33±0.1
7.62±0.12
7.52±0.07
7.17±0.04
7.33±0.05
7.2±0.06
7.25±0.05
7.1±0.02
7.33±0.11
7.68±0.02
7.58±0.09
7.16±0.02
7.42±0.05
7.2±0.07
7.38±0.09
7.63±0.08
7.36±0.15
7.55±0.06
7.4±0.09
6.05±0.08

7.44±0.06
7.35±0.05
7.54±0.07
7.33±0.08
7.39±0.1
7.47±0.1
7.48±0.08
6.81±0.14
7.47±0.11
7.32±0.09
7.57±0.07
7.1±0.02
7.25±0.12
7.57±0.1
7.64±0.09
7.23±0.09
7.46±0.09
7.16±0.07
7.38±0.05
7.09±0.04
7.29±0.12
7.74±0.03
7.49±0.14
7.12±0.04
7.37±0.04
7.19±0.07
7.36±0.11
7.57±0.07
7.2±0.1
7.55±0.07
7.47±0.13
5.89±0.19
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Chlorine(ppm)

3

Isolates

ATCC
251847
17978
134882
173795
474030
190451
163731
251352
4
ATCC
251847
17978
134882
173795
474030
190451
163731
251352
*Non significant at P> 0.05

A. baumannii (log10 CFU/ml)
30 sec
60 sec
90 sec

120 sec

7.47±0.05
7.16±0.05
7.45±0.1
7.59±0.07
7.31±0.15
7.58±0.07
7.53±0.06
6.15±0.04
7.37±0.1
7.19±0.07
7.38±0.12
7.65±0.09
7.39±0.15
7.53±0.04
7.51±0.05
6.19±0.16

7.31±0.1
7.19±0.06
7.36±0.08
7.57±0.08
7.32±0.13
7.56±0.07
7.57±0.07
6.07±0.05
7.21±0.11
7.3±0.15
7.29±0.06
7.63±0.1
7.36±0.16
7.52±0.05
7.56±0.09
6.08±0.15

7.44±0.06
7.21±0.06
7.41±0.09
7.61±0.08
7.48±0.17
7.56±0.06
7.46±0.03
6.16±0.05
7.31±0.09
7.17±0.1
7.62±0.11
7.61±0.09
7.34±0.16
7.54±0.04
7.61±0.04
6.14±0.14

7.31±0.05
7.17±0.06
7.38±0.04
7.61±0.09
7.47±0.16
7.5±0.1
7.44±0.06
6.16±0.07
7.23±0.09
7.34±0.16
7.3±0.07
7.62±0.09
7.25±0.11
7.55±0.05
7.53±0.06
6.14±0.16
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Fig 1: Effect of chlorine exposure on A. baumanniiATCC 17978 antibiotic resistance gene
expression

* Genes significantly different from the control atP< 0.05
Fig 2: Effect of chlorine exposure on A. baumannii 251847 antibiotic resistance gene expression

* Genes significantly different from the control at P< 0.05.
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Fig 3: Effect of chlorine exposure on A. baumannii 474030 antibiotic resistance gene expression

* Genes significantly different from the control at P< 0.05.
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Chapter V

A Real-Time quantitative PCR for specific detection of A. baumannii in water and blood.
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ABSTRACT
Multi-drug resistant (MDR) Acinetobacter baumannii is a major nosocomial pathogen
causing a wide spectrum of clinical conditions with significant mortality rates.Identification of A.
baumannii by traditional cultural methods requires at least 48 to 72 h for obtaining results. In
addition, biochemical methods for the confirmation of A. baumannii from other Acinetobacter
species are not completely accurate. Thus, there is a need for rapid methods for specific
identification of A. baumannii.
Polymerase chain reaction is a powerful molecular technique, which has been widely used
for detecting microorganisms. The objective of this study was to develop a real-time polymerase
chain reaction (RT-PCR) for specifically detecting A. baumannii in water and blood using TaqMan
primer/probe set targeting a highly conserved 102-bp DNA sequence in adeT, an efflux pump
found in A. baumannii. For testing the limit of detection, RT-PCR was done directly with 10-fold
dilutions of A. baumannii suspension in blood or water (106 CFU to 101 CFU) and various
concentrations of genomic DNA. Further, the sensitivity of the RT-PCR was tested after
enrichment of A. baumanniiin tryptic soy broth. The results revealed that all the A.
baumanniiisolates yielded a 102-bp PCR product, however, none of the tested negative control
isolates, including other Acinetobacter species produced any amplification. The sensitivity of
PCR for detecting A. baumannii in blood and water was 3 log10 CFU/ml or 0.1 ng/ml of DNA.
However, upon enrichment, the PCR was able to detect 2 log10 and 1 log10 CFU/ml of A.
baumanni in water after 6 h and 14 h of incubation at 37oC, respectively. The RT-PCR
developed in this study enabled specific detection of A. baumannii, and may be useful in the
rapid detection of the pathogen from environmental and clinical samples.
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1. INTRODUCTION
Acinetobacter baumannii is a Gram-negative, aerobic, coccobacillus belonging to the
family Moraxellaceae in the order Gammaproteobacteria (Peleg et al., 2008; Perez et al., 2007).
Acinetobacter species are ubiquitously present in soil and water, which are considered to be their
natural habitats (Baumann,et al., 1968). A. baumannii has also been detected in water systems
from multiple parts of the world (Ferreira et al., 2011; Zhang et al., 2013). In addition, A.
baumannii can persist in biofilms on a variety of abiotic surfaces for prolonged periods of time in
the hospital environment, thereby serving as a continuous source of infection. A. baumannii is
the most common bacterium associated with infections linked to intensive care units
(Giamarellou, 2010, Lambert et al., 2011), and it can cause a variety of nosocomial infections in
humans, including meningitis, pneumonia, urinary tract infections and bacteremia, with a high
mortality rate (Seifert et al., 1995; Dijkshoorn et al., 2007; Perez et al., 2007; Wisplinghoff et al.,
2004; Peleg et al., 2008; Pereira et al., 2013). During the last decade, A. baumannii has emerged
as an important human pathogen due to increasing reports of infections associated with the
organism and rapid emergence of multidrug-resistant (MDR), extensively-drug resistant (XDR),
and pandrug-resistant (PDR) strains (Peleg et al, 2008; Durante-Mangoni and Zarrilli, 2011). The
Infectious Diseases Society of America has ranked A. baumannii as one of the highest priority,
antibiotic-resistant pathogens to control due to its rapid propensity to develop drug resistance,
and the availability of a restricted choice of antibiotics to treat infections caused by the bacterium
(Talbot et al., 2006).
Bacteriological detection of A. baumannii by traditional cultural methods requires atleast 48
to 72 h for obtaining accurate results (Levi et al., 2003; Jamal et al., 2014). Furthermore, the four
Acinetobacter species, namely A. calcoaceticus (formerly Acinetobacter genomospecies 1), A.
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baumannii

(formerly Acinetobacter

genomospecies

2),

Acinetobacter

pitti

(formerly

Acinetobacter genomospecies 3) and Acinetobacter nosocomalis (formerly Acinetobacter
genomospecies 13TU) are phenotypically and genotypically closely related, and are difficult to
be distinguish from each other. Therefore, they are grouped together and referred to as A.
baumannii -A. calcoaceticus complex (ABC) (Gerner-Smidt et al., 1991; Gerner-Smidt, 1992).
Although several Acinetobacter species show hemolysis on sheep blood agar at 37oC, this
property, which is sometimes used for species identification is not exhibited by the members of
ABC complex (Peleg, 2008). In Gram staining procedure, Acinetobacter spp. is sometimes
difficult to de-stain, and depending on its stage of growth, can exhibit either Gram negative or
Gram positive characteristics (Howard et al., 2012). Moreover, species identification using
biochemical tests cannot differentiate A. calcoaceticus from A. baumannii, and specific detection
needs to be complemented by further tests, which could be time consuming in clinical diagnosis.
Thus, there is a need for accurate assays for specific detection of A.baumannii in clinical and
environmental samples.
Polymerase chain reaction (PCR) is a widely used method for rapid, specific and sensitive
detection of microorganisms (Garibyan and Avashia, 2013; Law et al., 2015).Real-time Taqman
PCR assays are faster and more sensitive than conventional PCR, and allow the quantification of
target DNA (Livak et al., 1995). The objective of this study was to develop and optimize a real
time-PCR for specific detection of A. baumannii from water and blood by targeting adeT, a RND
(resistance-nodulation-division) type efflux pump gene in A. baumannii not reported to be
present in any other bacteria.
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2. MATERIALS AND METHODS
2.1. Bacterial Strains and Growth Conditions
The various bacterial strains used in the study are listed in Table 1. A total of seventeen
clinical and environmental isolates of A. baumannii were used to study the specificity of the
PCR. The negative control isolates included important water- and blood-borne pathogens as well
as other Acinetobacter species from the ABC complex- A. calcoaceticus, A. nosocomalis and A.
pitti. Each strain of A. baumannii was individually grown on MDR Acinetobacter and Leeds
Acinetobacter agar plates (Hardy Diagnostics, Santa Maria, CA, USA), and a single colony from
these media was sub-cultured at least three times in tryptic soy broth (TSB; Difco, Becton
Dickinson, Sparks, MD, USA) for 24 h at 37oC. The bacteria used as negative controls were
cultured in TSB (Difco).
2.2. Preparation of Genomic DNA
The genomic DNA from Gram-negative and Gram-positive bacteria was extracted,as
previously described by Mohan Nair and Venkitanarayanan (2006). For testing the sensitivity of
PCR, A. baumannii DNA was extracted from one milliliter aliquots of sterile deionized water or
defibrinated sheep blood (Quad Five, Ryegate, MT, USA) containing 106, 105, 104, 103, 102, or
101 CFU using InstaGene Matrix (Bio-Rad, Hercules, CA, USA) or BiOstic bacteremia DNA
isolation kit (Mo Bio, Carlsbad, CA), respectively. Concurrently, the sensitivity of PCR was
also tested with serial dilutions of DNA ranging from 100 ng to 0.1 ng/l.
2.3. Detection of A. baumannii in water and blood on pre-enrichment
In order to increase the sensitivity of the PCR, an enrichment of the sample was done in
TSB (Mohan Nair and Venkitanarayanan, 2006; Afendy and Son, 2015), where one milliliter
aliquots of water or blood containing 103, 102 or 101A. baumannii were separately transferred to
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9 ml of TSB, and incubated at 37oC for 6 or 14 h. Following incubation, A. baumannii genomic
DNA was extracted and subjected to real-time PCR analysis.
2.4. Primers for A. baumannii specific PCR
Using Basic Local Alignment Search Tool (BLAST), a primer pair targeting A. baumannii RND
efflux pump gene adeT was designed. The forward primer (5’-CGGAATATCCGCTTTCATTT3’) and reverse primer (5’-GACAAATTAAAAGCTGGTTT-3’) target a highly conserved 102
bp region of the gene. The probe sequence was (5’ CGCGGTAACTGACCAGCCACC–3’) with
FAM- labeled on the 5’ end and TAMRA on the 3’ end. All oligonucleotides were synthesized,
labeled and purified by Integrated DNA Technologies (Coralville, IA, USA).
2.5. Real-Time TaqMan PCR Assay
Real-time TaqMan PCR assay was performed using StepOnePlus™ Real-time PCR detection
system (Applied Biosystems, Foster city, CA, USA). Thirty l reactions containing 15 l 2x
Taqman universal PCR master mix (Applied Biosystems), PCR primers at a concentration of 300
nM and the probe at 100 nM, and 6 lof DNA were prepared. The PCR parameters were 50oC
for 2 min, 95oC for 10 min and then 40 cycles at 95oC for 15s and 60oC for 1 min. The software
in the instrument calculates and plots the changes in the fluorescence signalfrom the probe (
Rn) versus the cycle number during the PCR reaction. Rn is calculated using the formula  Rn
= (Rn+) – (Rn-), where Rn+ is the fluorescence signal of the PCR product at a given time and
Rn- is the fluorescence signal of the baseline emission during the initial amplification cycles,
where no signal was detected. To determine the efficiency of the PCR, a standard curve was
plotted using the Ct number (cycle number at which the  Rn crosses the threshold) and log
CFU/ml of A. baumannii. The primer-probe set was subsequently tested using standard curve
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dilutions of the A. baumannii or A. baumannii DNA. Regression analyses of the data wasdone to
determine the correlation coefficient.
4. RESULTS AND DISCUSSION
Clinically, the rapid detection of A. baumannii is important for reducing the time before
patients receive appropriate treatment, which is especially critical in light of its multi-drug
resistance, and ability to cause a wide spectrum of infections with high mortality rates.
Moreover, accurate detection of A. baumannii in water is crucial as its ability to survive in water
may result in fatal infections in all age groups (Kempf et al., 2012). Therefore, this study was
undertaken to develop a real-time PCR for rapid and specific detection of A. baumannii in blood
and water. A literature search revealed that a few PCRs have been developed for the specific
detection of A. baumannii or multiplex detection for Acinetobacter spp. For example, McConnell
and group (2012) reported a real-time PCR based on the conserved sequence of ompA for
detecting A. baumannii. Although these researchers reported a high sensitivity for the PCR, they
failed to include A. calcoaceticus, A. nosocomalis and A. pitti from the ABC complex as negative
controls in the assay. Similarly, Higgins et al. (2007) developed a conventional PCR based on
gyrB for differentiating between A. baumannii and A. nosocomalis; however, they did not screen
the PCR with highly related A. calcoaceticus and A. pitti from the ABC complex. Recently, Chen
and coworkers reported a multiplex PCR based on 16S-23S ribosomal RNA intergenic region,
gyrB, and recA genes for the identification of A. baumannii, A. nosocomialis and A. pitti.
Although a large number of isolates were screened in the PCR, the authors did report 16 false
positives and 10 false negatives in their results (Chen et al., 2014).
The PCR developed in this study is based on a highly conserved 102-bp DNA sequence
of adeT, a RND type efflux pump gene reportedly present only in A. baumannii. The specificity
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of this DNA sequence was confirmed by BLAST analysis with all published prokaryotic gene
sequences, including related Acinetobacter sequences available in the NCBI GenBank database.
The specificity of the primers was further tested using In silico PCR (Bikandi et al., 2004), a
computational tool to detect the efficacy of primer-probe set to amplify the target DNA
sequence. The primer pair was used to amplify the target genomic DNA sequence from 17
strains of A. baumannii and 28 strains of other important bacteria,including members from the
ABC complex, and important water-borne bacteria such as Escherichia coli, Salmonella, Vibrio
cholera, Shigella and Pseudomonas, and other major pathogens such as Klebsiella pneumoniae,
Listeria monocytogenes and Yersinia pseudotuberculosis.All the isolates of A. baumannii
showed the amplification of a 102-bp DNA sequence within the targeted 40 cycles, whereas
none of the negative isolates, including the other members of the ABC complex yielded any
amplification (Fig. 1 and 2), thereby indicating that the PCR developed was able to specifically
detect A. baumannii.
The sensitivity of PCR was tested with DNA extracted from serial dilutions of A.
baumannii counts (ranging from 1 log10 to 6 log10 CFU/ml) present in water and blood. After 40
cycles of amplification, the PCR could detect as low as 3 log10 CFU/ml of A. baumannii in both
water (Fig 3A) and blood (Fig 4A). A standard curve showing the relation between the threshold
cycle and A. baumannii counts was plotted for detection in water (Fig 3B), where each point
represents A. baumannii count corresponding to the CT value. The regression analysis performed
with bacterial count as the independent variable and CT value as the dependent variable revealed
a correlation coefficient (R2) of 0.94. Similarly, the relationship between threshold cycle and A.
baumannii counts in blood was found to have a correlation coefficient of 0.99 (Fig 4B). The PCR
sensitivity was also tested with serial dilutions of A. baumannii DNA, where the lowest limit of
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detection was found to be 0.1ng/l of DNA (Fig 5A), with a correlation coefficient of 0.98 (Fig
5B).
Since the lowest detection limit of the PCR was 3 log10CFU/ml of A. baumannii both in
water and blood, a pre-PCR enrichment of the samples was done to improve the sensitivity of
PCR detection. The results revealed that enrichment for 6 h at 37oC improved the sensitivity of
detection to 2 log10 CFU/ml (Fig. 6A), whereas the PCR could detect as low as 1 log10 CFU/ml
of A. baumannii in water after 14 h of enrichment (Fig. 6B). However, the enrichment step failed
to improve the sensitivity of detection in blood samples, which remained at 3 log10 CFU/ml even
after enrichment (data not shown). This could be attributed to the presence of potential PCR
inhibitors such as heme (Akane et al., 1994), and hemoglobin and lactoferrin (Al-Soud et al.,
2001) present in blood.
In summary, the PCR reported in the manuscript was able to detect A. baumannii
specifically, without any false positives, especially from other species in the ABC complex. The
PCR could potentially be used for rapid detection of the pathogen from environmental and
clinical samples; however, further optimization for improving its sensitivity of detection in
clinical samples is warranted.
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Table 1: List of bacterial strains used in detecting specificity of PCR
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36

Species
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
A. baumannii
Acinetobactercalcoaceticus
Acinetobacter genomospecies 3
Acinetobacter genomospecies 13 TU
Burkholderia cepacia
Serratia marcescens
Escherichia coliK88
Yersinia pseudotuberculosis
Edwardsiella tarda
Proteus mirabilis
Proteus vulgaris
Aeromonas hydrophilia
Shigella flexneri
Edwardsiella ictaluri
Erwinia carotovora
Bacillus cereus
Klebsiella pneumoniae
Pseudomonas fragi
Salmonella Enteritidis
Salmonella enterica serovar typhi

Strain
189632a
260177 a
474030 a
190451 a
251847 a
251382 a
249958 a
252128 a
313099 a
195652 a
173795 a
163731 a
320452 a
134882 a
Naval 17b
OIFC 109 b
ATCC 17978
ATCC BAA-346
ATCC 17922
ATCC 17903
ATCC 25608
361c
842d
399 c
296 c
366 c
365 c
191 c
387 c
92/132 d
351c
F3802A/84 d
344 c
110 c
SE 90 d
372c
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37
38
39
40
41
42
43
45
46

Listeria monocytogenes
Staphylococcus aureus
Enterobacter aerogenes
Providencia alcalifaciens
Citrobacter fruendii
Chromobacterium violaceum
Pseudomonas fluorescence
Vibrio parahaemolyticus
Vibrio cholerae

Scott Ae
ATCC 35556
NRRL B-115f
368 c
239 c
294 c
105 c
ATCC 17802
ATCC 51394

a

International Health Management Associates (IHMA), Schaumburg, IL, USA
Bei resources, Manassas, VA
c
Presque Isle cultures, Presque Isle, PA
d
Culture collection, Food Microbiology Laboratory, University of Connecticut, Storrs, CT
e
M.P. Doyle, Center for Food Safety, University of Georgia, Griffin, GA
f
A. P. Rooney, Microbial Genomics and Bioprocessing Research Unit, Agricultural research Service Culture
Collection, USDA, Peoria, IL
b
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Fig 1: Specificity of the primer-probe set in differentiating A. baumannii from other members of
ABC complex

Fig 2: Specificity of the primer-probe set in differentiating A. baumannii from other important
Gram-negative and Gram-positive pathogens used as negative controls
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Fig 3: (A) Sensitivity of the primer-probe set in detecting A. baumannii in water
(B) Standard curve generated from the amplification plot (Fig 3A).R2 was calculated from plots
of measured CT (y axis) versus counts of A. baumannii log CFU/mlin water (x axis).

(A)

(B)
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Fig 4: (A) Sensitivity of the primer-probe set in detecting A. baumannii in blood
(B) Standard curve generated from the amplification plot (Fig 4A). R2 was calculated from plots
of measured CT (y axis) versus counts of A. baumannii log CFU/ml in blood (x axis).

(A)

(B)
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Fig 5: (A) Sensitivity of the primer-probe set in detecting A. baumannii DNA
(B) Standard curve generated from the amplification plot (Fig 5A). R2 was calculated from plots
of measured CT (y axis) versus A. baumanniiDNA (ng/l) (x axis).

(A)

(
b
)

(B)
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Fig 6: Sensitivity of the primer-probe set in detecting A. baumannii in water after enrichment
A. Following 6 h of incubation at 37OC (B) Following 14 h of incubation at 37OC

(A)

(B)
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Chapter VI

Effect of Trans-cinnamaldehyde and Eugenol on decreasing A. baumannii resistance to βlactam antibiotics.
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ABSTRACT
Multidrug resistant (MDR) Acinetobacter baumannii is a major nosocomial pathogen causing a
wide range of clinical conditions with significant mortality rates. A.baumannii strains are
equipped with a multitude of antibiotic resistance mechanisms, rendering them resistant to most
of the currently available antibiotics. Thus, there is a critical need to explore novel strategies for
controlling antibiotic resistance in A.baumannii. This study investigated the efficacy of two foodgrade, plant-derived antimicrobials (PDAs), namely trans-cinnamaldehyde(TC) and eugenol
(EG) in decreasing A.baumannii’s resistance to seven β-lactam antibiotics, including ampicillin,
methicillin, meropenem, penicillin, aztreonam, amoxicillin and piperacillin. Two MDR
A.baumannii isolates (ATCC 17978 and AB251847) were separately cultured in tryptic soy broth
(~6logCFU/ml) containing the m inimum inhibitory concentration (MIC) of TC or EG with or
without the MIC of each antibiotic at 37oC for 18 h. A.baumannii strains not exposed to the
PDAs or antibiotics served as controls. Following incubation, A.baumannii counts were
determined by broth dilution assay. In addition, the effect of PDAs on the permeability of outer
membrane and efflux pumps in A. baumannii was measured. Further, the effect of TC and EG on
the expression of A.baumannii genes encoding resistance to β-lactam antibiotics (blaP), efflux
pumps (adeABC) and multi-drug resistant protein (mdrp) was studied using real-time
quantitative PCR (RT-qPCR). The experiment was replicated three times with duplicate samples
of each treatment and control. The results from broth dilution assay indicated that both TC and
EG in combination with antibiotics increased the sensitivity of A.baumannii to all the tested
antibiotics (P<0.05). The two PDAs inhibited the function of A. baumannii efflux pump,
(AdeABC), but did not increase the permeability of its outer membrane. Moreover, RT-qPCR
data revealed that TC and EG down-regulated the expression of majority of the genes associated
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with β-lactam antibiotic resistance, especially blaPand adeABC (P<0.05).The results suggest that
TC and EG could potentially be used along with β-lactam antibiotics for controlling MDR
A.baumannii infections; however, their clinical significance needs to be determined using in vivo
studies.
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1. INTRODUCTION
Acinetobacter baumannii is a multi-drug resistant (MDR) Gram-negative, aerobic
bacillus that has emerged as a major cause of nosocomial infections with mortality rates ranging
from 34 to 61% (Wiexaorek et al., 2008; Karageorgopoulos and Falagas, 2008; Esterly et al.,
2011). In humans, MDR A. baumannii causes a wide-spectrum of clinical conditions, including
pneumonia (Leung et al., 2006), blood-stream infections (Wisplingoff et al., 2004; CDC, 2014),
meningitis (Metan et al., 2007), urinary tract infections (Sunenshine et al., 2007), and wound
infections (Scott et al., 2007). In addition, reports of other manifestations such as endocarditis,
peritonitis, and osteomyelitis associated with A. baumannii have been reported (Olut and Erkek,
2005; Menon et al., 2006; Wieczorek et al., 2008). A. baumannii is ranked as one of the most
common bacteria associated with intensive care units (Garnacho-Montero and Amaya-Villar,
2010; Ulu-Kilic et al., 2013), and is difficult to treat due to its resistance to most of the currently
available antibiotics (Maragakis and Perl., 2008; Doi et al., 2009; Neonakis et al., 2011; Al
Mobarak et al., 2014; Ellis et al., 2015). For example, carbapenems, which were once the
antimicrobials of choice for treating A. baumannii, are no longer completely effective due to
resistance development by the bacterium (Falagas et al., 2006; Bassetti et al., 2008; Abbott et
al., 2013; Fonseca et al., 2013). Similarly, although polymyxins have been successfully used to
treat A. baumannii infections, strains resistant to these drugs have appeared (Hernan et al., 2009;
Lean et al., 2014; Pogue et al., 2015). In light of these reports, the Infectious Diseases Society of
America ranked A. baumannii as one of the top priority, antibiotic-resistant pathogens to target
due to its rapid propensity to develop drug resistance, and a limited choice of antibiotics
available to treat infections caused by this bacterium (Talbot et al., 2006; Shales et al., 2013).
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A. baumannii is considered to be multidrug resistant, if it exhibits resistance to more than
three classes of antibiotics (Falagas et al., 2006). The resistance of A. baumannii to antibiotics
has been attributed to multiple mechanisms, including reduced permeability of its outer
membrane to antibiotics, constitutive expression of drug efflux pumps, and its ability to acquire
and incorporate genetic elements such as plasmids, transposons, and integrons (Giamarellou et
al., 2008; Cai et al., 2012). In addition, A. baumannii has a significantability to produce biofilms
on various surfaces (Espinal et al., 2012; Longo et al., 2014), which not only increases the
potential of A. baumannii for nosocomial spread, but also contributes to its resistance to
antibiotics and virulence (Lee et al., 2008; Rao et al., 2008). Thus, there is a critical need to
explore novel strategies for treating A. baumannii infections.
Traditionally, plants have served as a source of novel drugs for treating a variety of
diseases in humans (Cowan, 1999; FAO, 2013). A variety of plant-derived compounds
possessing antimicrobial properties against a wide range of microorganisms have been
documented (Kon and Rai, 2012; Upadhyay et al., 2014). Wang et al. (2010) reported the
antimicrobial effects of four components of ginger against MDR strains of the bacterium.
Similarly, the essential oil from coriander was found to exert either synergistic or additive effects
with antibiotics such as tetracycline, chloroamphenicol, ciprofloxacin, gentamicin, piperacillin
and cefoperazone against A. baumannii (Duarte et al., 2012).Recently, Saghi et al. (2015)
showed that the essential oil from Origanum vulgare possessed potent antimicrobial activity
against MDR A. baumannii. In addition, previous research from our laboratory indicated that
several plant-derived antimicrobials (PDAs), including trans-cinnamaldehyde, an ingredient in
cinnamon, eugenol (present in clove) and carvacrol and thymol obtained from oregano oil and oil
of thyme, respectively decreased antibiotic resistance in MDR S. Typhimurium DT 104
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(Kollanoor-Johny et al., 2010). These investigators observed that trans-cinnamaldehyde reduced
DT 104’s resistance to 5 antibiotics, where thymol and carvacrol decreased resistance to 3
antibiotics.
The β-lactam group of antibiotics are the most commonly prescribed antibiotics for the
treatment of bacterial infections worldwide (Pitout et al., 1997; Thakuria and Lahon, 2013). A.
baumannii is capable of producing β-lactamases that can hydrolyze the β-lactam ring of
penicillins, cephalosporins, and carbapenems, thereby conferring resistance to these antibiotics.
Therefore, this study investigated the efficacy of trans-cinnamaldehyde(TC) and eugenol (EG) in
increasing the sensitivity of A. baumannii to seven β-lactam antibiotics. In addition, the effect of
these PDAs on genes conferring resistance to β-lactam antibiotics in A. baumannii was
determined.
2. MATERIALS AND METHODS
2.1. A. baumannii Cultures and Growth Conditions
Two clinical isolates of A. baumannii, namely 251847 (International Health Management
Associates, IL), and 17978 (ATCC; fatal meningitis isolate) were used in the study.All
bacteriological media used in the study, except Leeds MDR Acinetobacter agar, were purchased
from Difco (Becton Dickinson, Sparks, MD, USA). Leeds MDR agar was procured from Hardy
Diagnostics (Santa Maria, CA, USA). The bacterial isolates were cultured separately overnight
in 10 ml tryptic soy broth (TSB), followed by streaking on Leeds MDR Acinetobacter agar plates
and incubation at 37oC for 24 h. An individual colonyfrom Leeds MDR Acinetobacter agar was
sub-cultured twice in 10 ml of TSB at 37oC for 24 h with agitation to reach ~ 8 log10 CFU/ml.
The cultures were sedimented by centrifugation (3700 x g, 15 min, 4oC) and the pellet was
washed twice and re-suspended in sterile phosphate buffered saline (PBS; pH 7.2). The cultures
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were then diluted appropriately in PBS to obtain 5 to 6 log10 CFU/ml to be used as the inoculum.
The bacterial populationin the inoculum was confirmed by plating on tryptic soy agar (TSA)
with incubation at 37oC for 24 h.
2.2. Plant-Derived Antimicrobials (PDAs) and chemicals
Trans-cinnamaldehyde (≥98%; TC, trans-3-Phenyl-2-propenal), Eugenol (≥98%; EG,4-Allyl-2methoxyphenol), 1- N-phenylnaphthylamine (NPN), EDTA, ethidium bromide (EtBr), carbonyl
cyanide m-chlorophenylhydroazone (CCCP) and pyronin Y were purchased from Sigma-Aldrich
(St. Louis, MO, USA).
2.3. Determination of sub-inhibitory concentration (SIC) and minimum inhibitory
concentration (MIC) of PDAs against A. baumannii
The SIC and MIC of TC and EG against A. baumannii were determined as previously reported
(Johny et al., 2010; Amalaradjou and Venkitanarayanan, 2011). Tryptic soy broth (10 ml) tubes
containing 1 to 10 lof TC or EG (Sigma-Aldrich) in increments of 0.5 lwere inoculated
separately with A. baumannii at ~ 6 log10CFU/ml, and incubated at 37oC for 24 h. Tubes without
any added PDAs served as controls. After incubation, the samples were serially diluted (1:10) in
PBS, plated on TSA, and incubated at 37oC for 24 h before counting the colonies. The highest
concentration of TC or EG that did not inhibit A. baumannii growth after 24 h of incubation was
selected as the SIC, while the lowest concentration of the antimicrobial that inhibited visible
growth of the bacteria after 24 h incubation was taken as the MIC of that treatment. The
experiment was done in duplicates and repeated three times.
2.4. Effect of PDAs on antibiotic resistance in A. baumannii
The β-lactam antibiotics tested in the current study included Ampicillin, Meropenem,
Methicillin, Penicillin, Aztreonam, Amoxicillin and Piperacillin (Sigma-Aldrich). Previously
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published MIC of each aforementioned antibiotic against A. baumanniiwas used in the study
(Table 2) (Vashist et al., 2011; Morfin-Otero and Dowzicky et al., 2012; Malone and Kwon,
2013).
To determine the effect of combination of PDAs and antibiotics on A. baumannii, the MIC
of each antibiotic and that of TC/EG were added to 10 ml TSB containing A. baumannii(~ 6
log10 CFU/ml), and incubated at 37oC for 24 h (Kollanoor-Johny et al., 2010). The bacterial
counts were determined after broth dilution assay and surface plating of appropriate dilutions on
TSA. The treatments included only A. baumannii (positive control), A. baumannii + antibiotic, A.
baumannii+ PDA and A. baumannii+ antibiotic + PDA. In addition, suitable controls, including
A. baumannii + diluent (ethanol) and A. baumannii + ethanol + antibiotic were also included.
Duplicate samples were included for each treatment, and the experiment was replicated three
times.
2.5. Efflux pump inhibition assay
To study the effect of TC and EG on inhibiting the action of efflux pumps in A.
baumannii, ethidium bromide (EtBr) and pyronin Y efflux assays were performed according to a
published protocol (Chusri et al., 2009). Overnight cultures of A. baumannii were washed twice
and resuspended in PBS containing 0.4 % glucose to an OD600 of ~ 0.5. The bacterial suspension
was added with the MIC of TC/EG or CCP (positive control, 100 M), and incubated at 37oC for
5 h. A. baumannii suspension in PBS + 0.4 % glucose served as control. After incubation, 200 l
of the treatments/control was separately transferred to a 96-well microtiter plate, followed by
addition of EtBr (Sigma) to a final concentration of 4 mg/l, and the fluorescence was measured at
excitation 530 nm and emission 645 nm. The assay was repeated with pyronin Y (Sigma) at a
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final concentration of 5 mg/l at 530 nm and emission 645 nm. The experiment was repeated three
times with duplicates for A. baumannii 17978 and A. baumannii 251847.
2.6. Outer membrane permeabilization assay
To study the effect of TC and EG on the outer membrane of A. baumannii, NPN uptake
assay was performed using a published protocol (Chusri et al., 2009). Overnight A. baumannii
17978 and A. baumannii 251847 cultures were separately washed and resuspended in 5 mM
HEPES buffer to an OD600 ~ 0.5. Aliquots of 100 l of A. baumannii suspension were transferred
to a microtiter plate along with the MIC of TC/EG or EDTA 1 mM/HEPES buffer. This was
followed by addition of 40 M of NPN to make the total volume to 200 l, the fluorescence was
measured within 3 min at excitation 355 nm and emission 460 nm, and continuously recorded for
3 h every 10 min. The experiment was repeated three times with duplicates in each treatment.
2.7. Effect of PDAs on antibiotic resistance gene expression in A. baumannii
2.7.1. RNA extraction and cDNA synthesis
To study the effect of TC and EG on genes associated with resistance to β-lactam
antibiotics in A. baumannii, bacterial cultures were grown separately with or without the SIC of
TC/EG at 37oC in TSB to mid-log phase. A. baumannii grown witheither antibiotic alone or PDA
alone were also included as controls. After incubation, the cultures were subjected to
centrifugation (12000 x g, 15 min, 4oC) and the resultant pellet was added with 0.5 ml of
RNAase free, sterile water and 1 ml of RNA protect reagent (Qiagen, Valencia, CA, USA). The
total RNA from each sample was extracted using the RNeasy mini kit (Qiagen), and the
manufacturer’s instructions were followed in estimating the total RNAusing Nanodrop
(ThermoFisher Scientific, Waltham, MA, USA). Super-script II reverse transcriptase kit
(Invitrogen, Carlsbad, CA, USA) was used for cDNA synthesis, and the resultant cDNA was
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used as a template for RT-qPCR. The amplified product was detected using SYBR Green
reagents.
2.7.2.Real-Time Quantitative PCR (RT-qPCR)
The antibiotic resistance genes of A. baumanniiassayedfor expression analysis included
efflux pump genes, namely adeA, adeB, adeC; β-lactam resistance gene,blaP; and the multidrug
resistance protein gene, mdrp. Primer Express software® (Applied Biosystems, Foster city, CA,
USA) was used for designing the primers specific for the genes and for the endogenous control
(16S rRNA). The primers were designed fromA. baumannii AB0057 genome (CP001182.1)
published in the NCBI database (Adams et al., 2008), and their sequences are provided in Table
1. The custom synthesized primers were obtained from Integrated DNA Technologies (Foster
City, CA, USA). RT-qPCR was performed with StepOnePlusTM Real Time PCR system
(Applied Biosystems) using the SYBR green assay (Applied Biosystems) under custom thermal
cycling conditions with the normalized RNA as the template (Bookout and Mangelsdorf, 2003).
Duplicate samples were analyzed and standardized against 16S rRNA gene expression. The
relative changes in mRNA expression levels were determined using comparative threshold cycle
(CT) method (2-CT) between the control and the treatments.
2.8. Statistical analysis
A completely randomized design with a factorial treatment structure was used. The
factors included two A. baumannii strains, seven antibiotics, and two PDAs. The data were
analyzed using the PROC GENMOD procedure of Statistical Analysis Software (SAS ver. 9.4;
SAS Institute Inc., Cary, NC). Least square means were considered significant at P< 0.05. The
data comparisons for gene expression study were made using Students t-test. The difference was
considered significant at P<0.05.
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3. RESULTS
The SICs of TC and EG against A. baumannii were found to be 1.1 mM (0.015 %) and 1.8
mM (0.03 %), respectively, while the MIC was 4 mM (0.05% TC and 0.065 % EG) for both
PDAs. Although a previously reported MIC of each antibiotic against A. baumannii was used in
the study, both A. baumannii isolates grew approximately by 2.0 log10CFU/ml after 24 h
(antibiotic control), as observed in Fig 1-4. In the presence of the MIC of TC, the bacterial count
after 24 h did not change significantly from the inoculation of level of 6.0 log10CFU/ml (Fig. 1
and 2) as expected. However, when A. baumannii was grown in the presence of each antibiotic
and TC, its growth after 24 h was significantly decreased in comparison to that in the positive
control, antibiotic control and TC control (P < 0.05). In both A. baumannii isolates, the greatest
sensitivity was observed to methicillin and lowest sensitivity was seen against ampicillin and
meropenem (Fig. 1 and 2). Similarly, the sensitivity of both A. baumannii isolates to all seven
antibiotics was significantly increased in the presence of EG, as indicated by the reduced growth
after 24 h (P < 0.05) (Fig. 3 and 4). In A. baumannii 17978, the greatest sensitivity was observed
against ampicillin (Fig. 3), whereas A. baumannii 251847 was maximally sensitive to amoxicillin
(Fig. 4).
The results of the efflux pump inhibition assay using EtBr and pyronin Y in A.
baumannii ATCC 17978 and A. baumannii 251847 are presented in Fig. 5-8. The MIC of TC
and EG resulted in an increased accumulation of EtBr inside bacterial cells, as indicated by an
increase in fluorescence compared to the PBS control (P<0.05) (Fig. 5-6).CCCP, an efflux pump
inhibitor used as a positive control (Magnet et al., 2001) also resulted in an increase in
fluorescene indicatingsupression of efflux pump in A. baumannii. However, a similar increase in
the fluorescence was not observed for pyronin Y compared to the PBS control (Fig. 7 and 8).
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The results of NPN uptake assay in A. baumannii ATCC 17978 and A. baumannii 251847 are
presented in Fig. 9 and Fig. 10, respectively. Neither TC nor EG increased NPN uptake, while
the EDTA control did show an increase in fluorescence. Further, the samples treated with TC or
EG demonstrated a decrease in fluorescence over time (data not shown).
The effect of seven antibiotics and two PDAs and their combination on the expression of
various antibiotic resistance genes in A. baumannii17978 is depicted in Fig. 11A-G. It was
observed that compared to control, the expression of all tested genes was up-regulated (P < 0.05)
following A. baumannii growth in the presence of the antibiotics. However, TC significantly
down-regulated the expression of major genes conferring resistance to β-lactam antibiotics
compared to control (P< 0.05). The genes encoding efflux pump adeA and adeB were down
regulated by ~ 6- and 9-fold, respectively. Moreover, the expression of genes encoding βlactamase (blaP) and the multiple drug resistance protein (mdrp) was decreased by ~3-folds(P<
0.05)Similar to the results observed with TC, all antibiotic resistance genes were down-regulated
on exposure to EG compared to control (P< 0.05). The expression of genes encoding efflux
pumps, adeA and adeB were down-expressed by 3- and 14- fold, respectively. Similarly, blaP
and mdrp were also down-regulated in both strains (P< 0.05). The combination of TC or EG with
the antibiotics also resulted in a down-regulation of majority of the tested genes (P< 0.05).
Among the combinations of TC or EG with the seven antibiotics, the combination
containingaztreonam resulted in a significant down-regulation of all the tested genes compared to
control (Fig. 11D). The combination of EG with piperacillin (Fig. 11C) or penicillin (Fig. 11F)
also significantly reduced the expression of all the antibiotic resistance genes (P < 0.05).
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4. DISCUSSION
Rapid emergence of antibiotic resistance in pathogenic microorganisms, especially to
multiple antibiotics has ignited research efforts to discover novel antibiotics and develop
effective derivatives of currently available antibiotics. However, few promising antibiotics are
under development, and the rapidity and complexity of resistance development in pathogens
have further exacerbated the situation. In light of this, a potential viable approach was explored
to reduce bacterial antibiotic resistance in the development of inhibitors of resistance
mechanisms in bacteria (Renau et al., 1999; Walsh and Fanning, 2008). This strategy involves
the co-administration of an antibiotic with an “inhibitor”, which counteracts bacterial resistance
mechanism(s), thereby rendering the resistant pathogen sensitive to the drug. The advantage of
this approach is that it makes it possible to continue the use of current antibiotics, for which indepth pharmacological and toxicological data are already available. In this regard, PDAs
represent a potential natural group of “inhibitors” of bacterial antibiotic resistance mechanisms.
Abundant literature exists on the antimicrobial properties of a variety of plant compounds
against a wide range of microorganisms (Upadhyay et al., 2014; Burt 2004), however, only a
handful of studies have addressed their effect on bacterial antibiotic resistance, especially in
Gram negative bacteria (Galluci et al., 2006; Chursi et al., 2009; Kollanoor-Johny et al., 2010;
Ilic et al., 2014). In the current study, both TC and EG enhanced the sensitivity of A. baumannii
to all seven β-lactam antibiotics tested (Fig. 1-4). This is evident from the significant reductions
in bacterial counts observed in the samples containing PDA and antibiotics as compared to that
in the treatments containing each PDA or antibiotic alone.
A. baumannii has been reported to exhibit resistance to β-lactam antibiotics through
several mechanisms, including the production of β-lactamases, changes in penicillin-binding
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proteins (PBPs), altering the structure and number of porin proteins, decreased membrane
permeability, and by use of efflux pumps that exit antibiotics out of the bacterial cell (Vila et al.,
2007; Manchanda et al., 2010; Bonin et al., 2013; Tang et al., 2014). Moreover, the presence of
efflux pumps and MDR proteins in A. baumannii contribute significantly to both intrinsic and
acquired resistance to antibiotics (Lomovskaya and Bostian, 2006). The A. baumannii genome
encodes a wide array of multidrug efflux systems, including AdeABC, a resistance-nodulationdivision (RND) family-type pump (Damier-Piolle et al., 2008;Wieczorek et al., 2008; Sun et al.,
2014; Yoon et al., 2013). The substrates for this pump include beta-lactams, aminoglycosides,
erythromycin, chloramphenicol, tetracycline, fluoroquinolone, trimethoprim, and ethidium
bromide (Magnet et al., 2001., Higgins et al., 2004; Heritier et al., 2005; Peleg et al., 2007). The
three component structures of AdeABC include the inner membrane fusion protein (AdeA),
transmembrane component (AdeB) and an outer membrane protein (AdeC), with the inactivation
of adeB resulting in the loss of pump function and multidrug resistance (Magnet et al., 2001).
In order to determine if TC or EG exerted an inhibitory effect on the aforementioned
efflux pumps in A. baumannii, an efflux pump inhibition assay was performed with EtBr and
pyronin Y along withCCCP, a documented efflux pump inhibitor(Magnet et al., 2001; Chusri et
al., 2009). Ethidium bromide and Pyronin Y are known substrates for AdeABC and AdeIJK
efflux pumps, respectively (Magnet et al., 2001; Chusri et al., 2009; Damier-Piolle et al., 2008;
Xing et al., 2014). Both TC and EG resulted in the inhibition of AdeABC efflux pump in the two
tested A. baumannii strains, as evident from the increase in fluorescence in the treated samples
compared to PBS control (Fig. 5 and 6). However, the PDAs did not exert any inhibitory effect
on the action of AdeIJK efflux pump in A. baumannii, as evident from the lack of difference in
fluorescence units between PDA-treated and PBS control samples (Fig. 7 and 8). Similarly, the

119

results from the NPN uptake assay revealed that TC and EG did not increase A. baumannii’s
outer membrane permeability, as seen from Fig. 9 and 10, where no increase in fluorescence was
observed in PDA-treated A. baumannii as against the samples treated with EDTA, a known outer
membrane permeabilizer in Gram-negative bacteria (Alakomi et al., 2006; Helander and
Sandholm, 2008). These results indicate that TC and EG increased the sensitivity of A.
baumannii to the tested antibiotics at least in part by inhibiting the efflux pump, AdeABC.
For ascertaining if TC or EG exerted an inhibitory effect on any of the antibiotic
resistance genes conferring resistance to β-lactam antibiotics in A. baumannii, we performed a
RT-qPCR on mRNA extracted from A. baumannii following growth in the presence and absence
of the PDAs. The results from the RT-qPCR revealed that TC and EG in combination with or
without each antibiotic significantly down-regulated the expression of the majority of genes that
confer resistance to β-lactam antibiotics (Fig. 11A-G). Among the various genes screened, those
encoding efflux pumps, adeA and adeB were maximally down-regulated by both PDAs. These
results concur with the results from the EtBr efflux pump inhibition assay, and suggest that TC
and EG enhanced the efficacy of the seven β-lactam antibiotics against A. baumannii by
thwarting the various resistance mechanisms, especially those involving the efflux pumps.
In conclusion, the results of this study suggest the potential use of TC and EG in
conjunction with the currently available β-lactam antibiotics for the treatment for MDR A.
baumannii infections. However, efficacy studies in suitable animal models are warranted before
recommending their clinical usage.
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Table 1: List of primers used in detecting A. baumannii antibiotic resistance genes
Gene
adeA (F)
(R)
adeB (F)
(R)
adeC (F)
(R)
blaP (F)
(R)
mdrp (F)
(R)
rRNA-16S(F)
(R)

Sequence (5’3’)
TGACCGACCAATGCACCTT
GCAACAGTTCGAGCGCCTA

Function
Efflux pump

CCGATGACGTATCGAAGTT
Efflux pump
T
CCGATGACGTATCGAAGTT
AGGA
ACGGCCCCAGAAGTCTAGT
Efflux pump
AGGA
CGATTAACCCCAATAACCC
TC
ACACTAGGAGAAGCCATGA
Beta-lactam resistance
AGTT
GCATGAGATCAAGACCGAT
AGCTT
Antibiotics
GTACGGCTTCTAGACCCAC
Multiple
drug resistance
AC
ACAAAGAGCCGTGCACAGT
CATTTT
proteincontrol
TCGCTAGTAATCGCGGATC
Endogenous
G
TT
GACGGGCGGTGTGTACAAG
Note: (F), A
forward; (R), reverse.
CGCTGGCGGC

Table 2: MIC of antibiotics used in testing against A. baumannii
Antibiotics
Ampicillin
Meropenem
Methicillin
Penicillin
Aztreonam
Amoxicillin
Piperacillin

MIC (μg/ml)
64
32
256
256
256
64
128
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Fig 1. Effect of TC in combination with β-lactam antibiotics in A. baumannii 17978
Bars with different superscripts differ from each other within a cluster (P < 0.05). A. baumannii
17978 was grown with each β-lactam antibiotic either alone or in combination with TC. Bacteria
not exposed to any treatments (PC) and bacteria exposed to only TC (TC Ctrl) served as controls
for the experiment.
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Fig 2. Effect of TC in combination with β-lactam antibiotics in A. baumannii 251847
Bars with different superscripts differ from each other within a cluster (P < 0.05). A. baumannii
251847 was grown with each β-lactam antibiotic either alone or in combination with TC.
Bacteria not exposed to any treatments (PC) and bacteria exposed to only TC (TC Ctrl) served as
controls for the experiment.
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Fig 3. Effect of EG in combination with β-lactam antibiotics in A. baumannii 17978
Bars with different superscripts differ from each other within a cluster (P < 0.05). A. baumannii
17978 was grown with each β-lactam antibiotic either alone or in combination with EG. Bacteria
not exposed to any treatments (PC) and bacteria exposed to only EG (EG Ctrl) served as controls
for the experiment.
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Fig 4. Effect of EG in combination with β-lactam antibiotics in A. baumannii 251847
Bars with different superscripts differ from each other within a cluster (P < 0.05). A. baumannii
251847 was grown with each β-lactam antibiotic either alone or in combination with EG.
Bacteria not exposed to any treatments (PC) and bacteria exposed to only EG (EG Ctrl) served as
controls for the experiment.
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Fig 5. Intracellular accumulation of ethidium bromide (EtBr) in A. baumannii ATCC 17978 after
treatment with MIC of TC and EG, as measured by fluorescence intensity
A. baumannii ATCC 17978 was added with MIC of TC/EG or CCCP (100 M) and incubated
for 5 h at 37oC. Fluorescence (excitation 530 nm and emission 645 nm) was measured after
addition of EtBr (4 mg/l). Treatments with * are significantly different from PBS (control) (P
<0.05)
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Fig 6. Intracellular accumulation of ethidium bromide (EtBr) in A. baumannii 251847 after
treatment with MIC of TC and EG, as measured by fluorescence intensity.
A. baumannii 251847 was added with MIC of TC/EG or CCCP (100 M) and incubated for 5 h
at 37oC. Fluorescence (excitation 530 nm and emission 645 nm) was measured after addition of
EtBr (4 mg/l). Treatments with * are significantly different from PBS (control) (P <0.05)
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Fig 7. Intracellular accumulation of pyronin Y in A. baumannii ATCC 17978 after treatment with
MIC of TC and EG, as measured by fluorescence intensity.
A. baumannii ATCC 17978 was added with MIC of TC/EG and incubated for 5 h at 37oC.
Fluorescence (excitation 530 nm and emission 645 nm) was measured after addition of pyronin
Y (5 mg/l). Treatments with * are significantly different from PBS (control) (P <0.05).
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Fig 8. Intracellular accumulation of pyronin Y in A. baumannii 251847 after treatment with MIC
of TC and EG, as measured by fluorescence intensity.
A. baumannii 251847 was added with MIC of TC/EG and incubated for 5 h at 37 oC.
Fluorescence (excitation 530 nm and emission 645 nm) was measured after addition of pyronin
Y (5 mg/l). Treatments with * are significantly different from PBS (control) (P <0.05)
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Fig 9. Effect of TC and EG on A. baumannii 17978 outer membrane, as measured by
fluorescence intensity. HEPES buffer (5.0 mM) was used as a control.
A. baumannii ATCC 17978 was added with MIC of TC/EG or EDTA (1 mM) and incubated for
5 h at 37oC. Fluorescence (excitation 530 nm and emission 645 nm) was measured after addition
of NPN (40 M). Treatments with * are significantly different from HEPES (control) (P <0.05).
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Fig 10. Effect of TC and EG on A. baumannii 251847 outer membrane, as measured by
fluorescence intensity. HEPES buffer (5.0 mM) was used as a control.
A. baumannii 251847 was added with MIC of TC/EG or EDTA (1 mM) and incubated for 5 h at
37oC. Fluorescence (excitation 530 nm and emission 645 nm) was measured after addition of
NPN (40 M). Treatments with * are significantly different from HEPES (control) (P <0.05).
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Fig 11. Effect of TC and EG on antibiotic resistance genes in A. baumannii 17978.
(A) A. baumannii 17978 was grown withthe SIC of TC/EG either alone or in combination with
amoxicillin, and RT-qPCR was done to test the effect of the treatments on major antibiotic genes
in A. baumannii. Bacteria exposed to amoxicilllin alone and bacteria not exposed to any
treatments served as controls. Bars with * are significantly different from control (P <0.05).
20
15

Relative fold change

10
5
adeA

0

adeB

*

-5

*

*

blap
mdrp

-10

*

-15

*

-20
-25 Control

Amx*

TC*

EG*

Amx+TC

Amx+EG

139

(B) A. baumannii 17978 was treated with SICs of TC/EG either alone or in combination with
ampicillin and RT-qPCR was done to test the effect of the treatments on major antibiotic genes
in A. baumannii. Bacteria exposed to ampicillin alone and bacteria not exposed to any treatments
served as controls. Bars with * are significantly different from control (P <0.05).
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(C) A. baumannii 17978 was treated with SICs of TC/EG either alone or in combination with
piperacillin and RT-qPCR was done to test the effect of the treatments on major antibiotic genes
in A. baumannii. Bacteria exposed to piperacillin alone and bacteria not exposed to any
treatments served as controls. Bars with * are significantly different from control (P <0.05).
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(D) A. baumannii 17978 was treated with SICs of TC/EG either alone or in combination with
aztreonam and RT-qPCR was done to test the effect of the treatments on major antibiotic genes
in A. baumannii. Bacteria exposed to aztreonam alone and bacteria not exposed to any treatments
served as controls. Bars with * are significantly different from control (P <0.05).

Relative fold gene expression

10
5
adeA

0

adeB
-5

blap

-10

mdrp

-15
-20
-25

PC

Azt*

TC*

EG*

Azt + TC*

Azt + EG*

142

(E) A. baumannii 17978 was treated with SICs of TC/EG either alone or in combination with
meropenem and RT-qPCR was done to test the effect of the treatments on major antibiotic genes
in A. baumannii. Bacteria exposed to meropenem alone and bacteria not exposed to any
treatments served as controls. Bars with * are significantly different from control (P <0.05).
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(F) A. baumannii 17978 was treated with SICs of TC/EG either alone or in combination with
penicillin and RT-qPCR was done to test the effect of the treatments on major antibiotic genes in
A. baumannii. Bacteria exposed to penicillin alone and bacteria not exposed to any treatments
served as controls. Bars with * are significantly different from control (P <0.05).
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(G) A. baumannii 17978 was treated with SICs of TC/EG either alone or in combination with
methicillin and RT-qPCR was done to test the effect of the treatments on major antibiotic genes
in A. baumannii. Bacteria exposed to methicillin alone and bacteria not exposed to any
treatments served as controls. Bars with * are significantly different from control (P <0.05).
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Chapter VII

Efficacy of trans-cinnamaldehyde and eugenol in reducing A. baumannii adhesion to and
invasion of human keratinocytes and controlling wound infections in vitro
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ABSTRACT
Acinetobacter baumannii is a multi-drug resistant, nosocomial pathogen causing a variety of
disease conditions in humans. After A. baumannii outbreaks in military combat personnel in Iraq
and Afghanistan, reports of A. baumannii wound infections are increasingly recognized. In
addition, A. baumannii’s ability to form biofilms and colonize epithelial cells potentially
increases the invasiveness of this pathogen. Thus, in light of the multidrug resistance and biofilm
producing capacity, new strategies for controlling A. baumannii wound infections are necessary.
This study investigated the efficacy of two natural, plant-derived antimicrobials (PDAs), namely
trans-cinnamaldehyde (TC) and eugenol (EG) for decreasing A. baumannii adhesion to and
invasion of normal human keratinocytes (HEK001). The efficacy of two PDAs for inhibiting A.
baumannii biofilm formation was determined using an in vitro collagen matrix wound model. In
addition, the effect of TC and EG on A. baumannii biofilm architecture was visualized using
confocal scanning microscopy. Further the effect of both PDAs on A. baumannii genes critical
for biofilm synthesis was determined using real-time quantitative PCR (RT-qPCR). Both TC and
EG significantly reduced A. baumannii adhesion to HEK001 by ~2 to 2.5 log10 CFU/ml (P <
0.05), and invasion by ~2 to 3 log CFU/ml, compared to the controls (P < 0.05). Further, after 24
and 48 h, TC inhibited biofilm formation by ~1.5 and ~2 to 3.5 log10 CFU/ml, while EG
decreased biofilm-associated bacteria by ~2 and ~3.5 log10 CFU/ml, respectively, compared to
controls (P < 0.05). Confocal microscopy revealed that TC and EG resulted in the death of
biofilm-associated A. baumannii, and disrupted the biofilm architecture. RT-qPCR results
indicated that the two phytochemicals significantly down-regulated the transcription of genes
associated with A. baumannii biofilm production. The results suggest that both TC and EG could
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potentially treat A. baumannii wound infections; however, their efficacy in in vivo models needs
to be validated.
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1. INTRODUCTION
Acinetobacter baumannii has emerged into a significant human pathogen, especially
linked to infections acquired from hospital settings, with high case fatality rates
(Karageorgopoulos and Falagas, 2008; Wieczaorek et al., 2008; Esterly et al., 2011). In addition,
A. baumannii has the ability to form biofilms on a variety of biotic and abiotic surfaces (Gaddy
et al., 2009). The ability of A. baumanniito persist in the nosocomial environment is the most
important factor aiding in the transmission of infection in nursing homes and nosocomial settings
(Simor et al., 2002; Denton et al., 2005; Rastogi et al., 2007). During the last few years, A.
baumannii has become resistant to the majority of currently available antibiotics, and the
emergence of multidrug-resistant (MDR), extensively-drug resistant (XDR), and pandrugresistant (PDR) strains have been documented (Peleg et al, 2008; Durante-Mangoni and Zarrilli,
2011). This has generated concern among health-care professionals due to the limited choice of
drugs available for controlling A. baumannii infections, especially in light of its ability to cause a
wide range of infections, including pneumonia, bacteremia, meningitis and urinary tract
infections (Bergogne-Bérézin and Towner, 1996; Peleg et al., 2008). In addition to these
conditions, MDR A. baumannii has been increasingly linked to skin and soft-tissue infections
(Ali et al., 2014). Further, A. baumannii is an important pathogen causing persistent wound
infections in burn victims, leading to loss of skin grafts and delayed wound healing (BergogneBerezin, 1995; Santucci et al., 2003; Sharma, 2007). During the last decade, the US military
health care system has recorded a significant increase in the incidence of MDR A. baumannii in
combat-related wound infections (Scott et al., 2007; Murray, et al., 2008).
Traditionally, the management of wound infections consists of using gauze and cotton
wool to protect the wound from outside contamination (Jones et al., 2006), coupled with creams
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or powders incorporated with topical bioactive agents that either act as antimicrobial drugs or
aacelerate the wound healing process (Katti et al., 2004; Dai et al., 2010). Antibiotics such as
minocycline, vancomycin, neomycin and streptomycin incorporated in novel delivery systems
such as chitosan, polyox and carrageenan have been found effective in the treatment of wounds
(Aoyagi et al., 2007; Labovitiadi et al., 2012; Boateng et al., 2013; Pawar and Rhee., 2014).
However, the multi drug resistance of A. baumannii combined with the inefficacy of systemic
antibiotics in reducing pathogen loads in granulation wounds has necessitated alternate strategies
for treating and controlling wound infections caused by the pathogen (Selcuk et al., 2012;
Thompson et al, 2014).
Several plant-derived compounds have been investigated for their potential would healing
properties. Aloe vera was reported to inhibit bacterial growth and enhance wound healing by
stimulating macrophage activity (Djeraba and Quere, 2000; Ni, 2004). Plant compounds such as
curcumin haveaccelerated healing of irradiated wounds in mice (Jagetia and Rajanikant, 2012).
The treated mice had an increased collagen deposition, fibroblast and vascular densities
compared to untreated mice. Similarly, essential oils from citrus, thyme, and cinnamon have
exhibited wound-healing properties in vivo and/or in vitro (Dursun et al., 2003; Woollard et al.,
2007; Ranasinghe et al., 2013). Liakos et al. (2014) reported the efficacy of essential oils such as
cinnamon, elicriso italic, chamomile blue or lemon incorporated at 66% (dry weight percentage)
in sodium alginate films against E. coli and C. albicans, and proposed their application as
disposable wound dressings. Chitosan films incorporated with thyme oil were also effectively
applied as antibacterial and permeable films for wound healing (Altoik et al., 2010). Farahpour
and Habibi (2012) reported that extracts of cinnamon improved the healing of excised wounds in
rats by increasing epithelialization. Similarly, Kamath et al. (2003) observed that oral
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supplementation of ethanolic extracts of cinnamon bark increased the rate of wound contraction
and granulation tissue weight in Wistar rats. Additional studies revealed that phytochemicals
such as trans-cinnamaldehyde and eugenol did not produce any detrimental effect on
keratinocyte cell growth and proliferation (Daker et al., 2013; Kalmes and Blomeke et al., 2012).
The objective of this study was to investigate the efficacy of trans-cinnamaldehyde and
eugenol in reducing the adhesion and invasion of A. baumannii in human keratinocytes, and to
inhibit A. baumanniibiofilm formation in an in vitro wound model.
2. MATERIALS AND METHODS
2.1. Bacterial strains and growth conditions
Three clinical isolates of A. baumannii isolated from wound infections (Navel-17, OIFC109 and WC-487) (BEI resources, Manassas, VA, USA) were used in the study. Each strain was
cultured separately in 10 ml of Tryptic soy broth (TSB, Difco, Becton Dickinson, Sparks, MD,
USA) at 37oC for 24 h to reach an optical density at 600 nm of ≥ 0.7, yielding ~ 8 logCFU/ml.
The cultures were sedimented by centrifugation (3,600 X g, 15 min at 4oC), the pellet was
washed twice, re-suspended in sterile PBS, and used as the inoculum. The A. baumannii
population in the inoculum was determined by serial dilution and plating on Tryptic soy agar
(TSA, Difco) with incubation at 37oC for 24 h.
2.2. Plant-Derived Antimicrobials (PDAs)
Trans-cinnamaldehyde (≥98%; trans-3-Phenyl-2-propenal, TC) and eugenol (≥98%; 4-Allyl-2methoxyphenol, EG) were purchased from Sigma-Aldrich (St. Louis, MO, USA).
2.3. Determination of Sub-inhibitory concentrations (SIC) and Minimum inhibitory
concentration (MIC) of PDAs
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The SIC and MIC of TC and EG against A. baumannii were determined as previously reported
(Amalaradjou and Venkitanarayanan, 2011; Kollanoor-Johny et al., 2010). Tryptic soy broth (10
ml) tubes containing 1 to 10 l of TC or EG (Sigma-Aldrich) in increments of 0.5 lwere
inoculated separately with A. baumannii at ~6 log10CFU/ml, and incubated at 37oC for 24 h.
Tubes without any added PDAs served as controls. After incubation, the samples were serially
diluted (1:10) in PBS, plated onTSA, and incubated at 37oC for 24 h before counting the
colonies. The highest concentration of TC or EG that did not inhibit A. baumannii growth after
24 h of incubation was selected as the SIC, whereasthe lowest concentration of eachantimicrobial
that inhibited bacteria growth after 24 h incubation was selected as the MIC of that treatment.
The experiment was done in duplicates and repeated three times.
2.4. Keratinocyte cell culture
Human skin keratinocyte, HEK001 (ATCC CRL-2404) was obtained from the American
Type Culture Collection (Manassas). HEK001 cells were grown in a 25 cm2 cell culture flask
containingkeratinocyte serum free medium (K-SFM) supplemented with human recombinant
epidermal growth factor (Invitrogen, Carlsbad, CA, USA) at 37oC for 24-48 hin an aerobic
incubator containing 5% CO2.
2.5. Adhesion and invasion assay
The effect of MIC of TC and EG on A. baumannii adhesion to and invasion of HEK001
keratinocyte cellswas determined, aspreviously described (Muthaiyan et al., 2012). Twenty fourwell tissue culture plates (BD, Franklin Lakes, NJ, USA) were seeded with ~105 cells/well, and
incubated at 37oC for 24 h in 5% CO2 incubatorto form a monolayer. A. baumannii was grown to
mid-log phase at 37oC, washed and re-suspended in K-SFM with MIC of TC or EG. Bacteria
suspended in K-SFM alone or with ethanol (diluent) were used as controls. Aliquots of 100 μl of
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the bacterial suspension containing approximately 6 log10CFU/well (MOI 1:10) was inoculated
in duplicates into the HEK001 monolayer, and incubated at 37oC in 5% CO2 incubator for 2 h.
For the adhesion assay, the infected monolayers after incubation was washed three times with
PBS, and the cells were lysed using 0.1 % Triton X-100 (Invitrogen). The number of viable
adhered bacteria was enumerated by serial dilution and culturing on TSA plates. For the invasion
assay, the HEK001 monolayer was washed three times with PBS, followed by incubation for 2 h
in K-SFM containing gentamicin (100 μg/ml) (Invitrogen) in order to kill the extracellular
bacteria. Subsequently, the wells were washed three times with PBS and the cells were lysed
using 0.1 % Triton X-100 to release the intracellular bacteria. The number of invaded bacteria
was enumerated by serial dilution in PBS and culturing on TSA plates. Both adhesion and
invasion assays were done in duplicates and the experiment was repeated three times.
2.6. Quantification of biofilm in invitro
In order to replicate the conditions of a chronic wound, an in vitro system that
accommodates bacterial aggregates in a simulated wound fluid and collagen matrix model, as
described by Werthen et al., (2010) was used. Briefly 24-well cell culture plates were coated
with collagen solution (rat tail collagen type 1, BD Biosciences, San Jose, CA). A 10 ml collagen
solution (2 mg/ml) contained 1 ml of 0.1% acetic acid, 2 ml collagen stock solution (10 mg/ml)
and 6 ml cold simulated wound fluid (SWF, 50% fetal calf serum and 50% physiological NaCl in
0.1% peptone) and 1 ml of 0.1 M NaOH. One ml of the above solution was added to each 24well plate, which wasincubated at 37oC for 1 h. After complete polymerization, A. baumannii (5
log10 CFU/ml) was suspended in SWF with or without the MIC of PDAs to each well in
duplicates. The plates were incubated for 48 h, and the polymerized collagen was subsequently
dissolved using collagenase solution (500 μl/ml in PBS), followed by incubation for 60 min at

153

37oC. A. baumannii counts were determined using serial dilution and plating on TSA. The
experiment was repeated three times.
2.7. Confocal microscopy
The three-dimensional structure of A. baumannii biofilm treated with or without TC or EG
was visualized in situconfocal laser scanning microscopy using a Leica true confocal scanner
SP2 microscope with a water immersion lens (Loehfelm et al., 2008). A. baumannii exposed to
the MIC of TC or EG in TSB was allowed to form biofilms on a Lab-Tech eight-chamber no.1
borosilicate glass coverslip system (Lab-tek, Nalge Nunc International, Rochester, NY, USA) by
incubating it at 37oC for 48 h, followed by gently washing with PBS three times. The live and
dead bacteria in the biofilm were imaged after staining with 2.5 M Syto9 (Molecular Probes,
Eugene, Oregon, USA) and 5 M propidium iodide (Molecular Probes) for 5 min prior to
imaging on a Nikon AIR laser scanning confocal. Syto9 is a live cell permanent DNA stain,
while propidium iodide is a nucleic acid stain that can only enter dead or dying cells. Syto
staining was imaged with 488 nm excitation and a 525/50 emission filter, whereas propidium
iodide staining was imaged with 560 nm excitation and a 600/50 emission filter. For each
treatment, four randomly selected fields were analyzed. Optical sections of approximately 0.2
μm in height were collected starting from the bottom and moving upward through the entire
biofilm.
2.8.Effect of TC and EG on biofilm genes in A. baumannii
2.8.1. RNA extraction and cDNA synthesis
To study the effect of TC and EGon genes critical for biofilm formation in A. baumannii,
bacterial cultures (Navel-17, OIFC-109) were grown separately in TSB with or without the SIC
of TC or EG at 37oC to mid-log phase. Control without any PDA was also included. After
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incubation, the cultures were subjected to centrifugation (12000 x g, 15 min, 4oC), and the
resultant pellet was added with 0.5 ml of RNAase free, sterile water and 1 ml of RNA protect
reagent (Qiagen, Valencia, CA, USA). The total RNA from each sample was extracted using the
RNeasy mini kit (Qiagen), and the manufacturer’s instructions were followed in estimating the
total RNAusing Nanodrop (ThermoFisher Scientific, Waltham, MA, USA). Super-script II
reverse transcriptase kit (Invitrogen, Carlsbad, CA, USA) was used for cDNA synthesis, and the
resultant cDNA was used as the template for RT-qPCR. The amplified product was detected
using SYBR Green reagents.
2.8.2. Real-Time Quantitative PCR (RT-qPCR)
The biofilm genes of A. baumannii analysed for the gene expression study included csuE,
that codes for putative tip adhesin critical forinitiation of biofilm formation (Gaddy and Actis,
2009); bfmS, a component of the regulatory system that controls csuE (Liou et al., 2014); and
ompA, a critical gene for attachment to eukaryotic cells for biofilm formation (Liou et al., 2014).
Previously published primers were used for csuE and bfmS, while the primer pair for ompA was
designed using Basic Logic Alignment Search Tool (BLAST) (Table 1). The custom synthesized
primers were obtained from Integrated DNA Technologies (Foster City, CA, USA). RT-qPCR
was performed with StepOnePlusTM Real Time PCR system (Applied Biosystems, Foster city,
CA, USA) using the SYBR green assay (Applied Biosystems) under custom thermal cycling
conditions with the normalized RNA as the template (Bookout and Mangelsdorf, 2003).
Duplicate samples were analyzed and standardized against 16S rRNA gene expression. The
relative changes in mRNA expression levels were determined using comparative threshold cycle
(CT) method (2-CT) between the control and the treatments.
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2.9. Statistical analysis
A completely randomized design was used for the study. All the experiments had
duplicate samples and were repeated three times. The data for each treatment and control were
pooled and analyzed using the PROC GENMOD procedure of Statistical Analysis Software
(SAS ver. 9.4; Institute, Inc., Cary, NC, USA). A Pvalue of < 0.05 was considered to be
statistically significant.
3. RESULTS AND DISCUSSION
Skin is the largest organ in the human body and constitutes an integral part of the innate
immune system; it is the first line of defense against any infection by preventing microbial
adhesion and invasion (Nizet et al., 2001; Schroder and Harder, 2006). Skin is colonized with
microbial populations consisting of resident flora and transient microflora (Price, 1938;
Mackowiak, 1982). However, when a disruption occurs to the anatomical structure of the skin,
an onset of infection can happen, if the homeostatic physiological conditions are not rapidly
restored (Boateng and Catanzano, 2015). While studying the distribution of Acinetobacter
species on human skin, Seifert et al. (1997) reported that Acinetobacter spp. colonized in 75% of
patients, with the colonization rates increasing with the length of stay in hospitals. A. baumannii
is considered as one of the most significant bacteria causing persistent wound infections,
especially in burn patients (Uygur et al., 2009) and combat-related injuries (Johnson et al., 2007;
Scott et al., 2007). Previous studies have reported the formation of biofilms by A. baumannii on
human skin surfaces (Guerrero et al., 2010; deBreij et al., 2012). Besides its multi-drug
resistance, difficulties in treating A. baumannii wound infections areattributed to its ability to
form biofilms, which resist the action of host immune defenses as well as antimicrobial
interventions, thereby delaying the healing process (Dallo and Weitao, 2010). Bacterial biofilms
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are also important in chronic wound infections (Martin et al., 2010);60% of the chronic wounds
testedin hospitals containbiofilms (James et al., 2008). Although it is not clearly recognized how
the wound-associated microflora affect healing (Percival et al., 2012), pathogens are known to
produce extracellular adherence proteins which can inhibit action of leucocytes besidesexerting
anti-angiogenic and anti-inflammatory effects (Athanaspoulos et al., 2006). Therefore, in this
study, we investigated efficacy of TC and EG in reducing A. baumannii colonization of human
keratinocytes as well as inhibiting its biofilm in an in vitro wound model (Werthen et al., 2010).
The SIC of TC and EG against A. baumannii were found to be 1.1 mM (0.015 %) and 1.8
mM (0.03 %), respectively, while the MICs of TC and EG were 4.0 mM (0.05% TC and 0.065 %
EG (data not shown). The efficacy the MIC of TC and EG in reducing adhesion to and invasion
of keratinocytes HEK001 by three clinical strains of A. baumannii is presented in Fig 1-3. The
results revealed that both TC and EG were effective in reducing A. baumannii adhesion to and
invasion of HEK001 cells compared to the controls (P < 0.05). The MIC of TC reduced A.
baumannii adhesion and invasion of keratinocytes by ~1.8 to 2 log CFU/ml, while EG reduced
adhesion and invasion of cells by ~2 log and ~2.5-3 log10 CFU/ml, respectively compared to
controls (P < 0.05). No significant difference was observed between TC and EG in reducing A.
baumannii adhesion to HEK001 cells, however, EG was found to be more effective than TC in
reducing invasion in A. baumannii Naval-17 (P < 0.05). Ethanol, which was used as a diluent for
TC and EG, did not exert any significant effect on the adhesion-invasion properties of A.
baumannii compared to control (P > 0.05).
The effect of PDAs on A. baumannii biofilm formation in the in vitro wound model is
presented in Fig. 4-6. The MIC of both TC and EG significantly reduced biofilm-associated A.
baumannii counts after 24 and 48 h of incubation at 37OC compared to control (P < 0.05). After
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24 h of incubation, the MIC of TC and EG resulted in ~1.510 log and ~2 log10 CFU/ml reduction
in A. baumannii counts respectively, compared to control (P < 0.05). However, after 48 h of
incubation, TC and EG decreased A. baumannii counts by ~ 3-3.5 log10 CFU/ml and ~ 4 log
10CFU/ml,

respectively compared to control (P < 0.05). In addition, EG was generally found to

be more effective than TC in inhibiting biofilm, particularly in A. baumannii Naval-17 (P <
0.05).
The effect of TC and EG on A. baumannii biofilm structure, as revealed by confocal laser
scan microscopy, is depicted in Fig 7. In A. baumannii not exposed to TC/EG (control), a thick
uniform layer of biofilm embedded with live cells (stained green by SYTO Green dye) was
observed (Fig 7A), while A. baumannii treated with the MIC of TC and EG revealed breaks in
the biofilm with the presence of dead cells (stained by red propidium iodide dye) (Fig 7 B-C). In
addition, the thickness of the biofilms in the treatments (<10 m) was lesser than in controls (>
20 m).
The effect of PDAs on the expression of critical biofilm genes in A. baumannii is
depicted in Fig. 8-10. It was observed that in A. baumannii Naval -17 when compared to the
control, TC significantly down-regulated the expression the expression of bfms, csuE and ompA
by ~2.5, ~1.5 and ~2.5 folds, respectively (P < 0.05). Similarly, EG was found to decrease the
expression of bfms, csuE and ompA by ~ 3.5, 6 and 4 folds, respectively (Fig 8). In A. baumannii
OIFC 109, TC down-regulated the expression of bfmS and csuE by ~2.7 and ~16 fold,
respectively (P < 0.05), while EG decreased the expression of bfmS, csuE and ompA by ~25, ~11
and ~23 folds, respectively (P <0.05) (Fig 9). These results support the findings from the in vitro
wound biofilm assay as well as the confocal microscopy result.
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The efficacy of antibiotics for treating A. baumannii wound infections is limited owing to
its multi-drug resistance (Karageorgopoulos and Falagas, 2008; Giamarellou et al., 2008).
Although studies have shown the efficacy of chlorhexidine as an antiseptic for skin disinfection
of A. baumannii (Evans et al., 2010; de-Breij et al., 2012), it has been implicated to exert toxicity
to fibroblasts and prevent wound healing (Lucarotti et al., 1990; Hidalgo and Dominquez, 2001).
In addition, A. baumannii resistant to 1% chlorhexidine has been isolated from surfaces of soap
dispensers (Brooks et al., 2002). The results from this study indicated that TC and EG were
effective for reducing A. baumannii colonization of skin cells, and inhibiting bacterial biofilm
formation in a collagen matrix. Therefore, TC and EG represent potential antimicrobial agents
for treating A. baumannii wound infections, where they could be used as ingredients in
antimicrobial ointments and creams. However, follow up studies on their safety and efficacy in
an appropriate animal model are necessary before recommending their clinical application.
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Table 1. List of primers used for RT-PCR for targeting biofilm genes in A. baumannii

a

Gene
bfmSa (F)

Sequence (5’3’)
TCGGCGGGTATTACCTTATTTAGCT

(R)

GCCTCAATCAAACGCTGAATATGGT

csuEb(F)

TACTGGTTTGGCCTATCC

(R)

CGTAAAGCTACTCATGTC

ompA(F)

GGTATTGGAGCTGGTTTATCTTCT

(R)

GATTTTCCCGTAGTCTCTGTTGCT

rRNA-16S(F)

TGGCTCAGATTGAACGCTGGCGGC
G

(R)

TACCTTGTTACGACTTCACCCCA
CGCTGGCGGC

Function
Biofilm
formation
response
regulator
Putative tip
adhesion
Attachment
to
eukaryotic
cells
Endogenous
control

Liou et al., 2014; bDorsey et al., 2002
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Fig 1. Effect of Trans-cinnamaldehyde (TC) and Eugenol (EG) on A. baumannii Naval-17
adhesion to and invasion of HEK001 keratinocytes. A. baumannii either alone or with
TC/EG/ethanol (diluent) was added to HEK001 monolayer. The adhered or invaded bacterial
counts were determined by broth dilution.
Bars with different superscripts differ from each other (P < 0.05).

167

Fig 2. Effect of Trans-cinnamaldehyde (TC) and Eugenol (EG) on A. baumannii OIFC 109
adhesion to and invasion of HEK001 keratinocytes.
A. baumannii either alone or with TC/EG/ethanol(diluent) was added to HEK001 monolayer.
The adhered or invaded bacterial counts were determined by broth dilution.
Bars with different superscripts differ from each other (P < 0.05).
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Fig 3. Effect of Trans-cinnamaldehyde (TC) and Eugenol (EG) on A. baumannii WC-487
adhesion to and invasion of HEK001 keratinocytes
A. baumannii either alone or with TC/EG/ethanol(diluent) was added to HEK001 monolayer.
The adhered or invaded bacterial counts were determined by broth dilution.
Bars with different superscripts differ from each other (P < 0.05).
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Fig 4. Effect of Trans-cinnamaldehyde (TC) and Eugenol (EG) on A. baumannii Naval -17
biofilm in an in vitro wound model. A. baumannii exposed to MICs of TC/EG were allowed to
form a biofilm on a collagen matrix at 37OC. Bacterial counts were enumerated after 24 and 48 h
of incubation.Bars with different superscripts differ from each other (P < 0.05).

A. baumannii Naval-17
CFU/mL

10
8

0h
a

b

b

24h
a

6

a

c

d

48h

d

4

e

2
0
Control

TC

EG

170

Fig 5. Effect of TC and EG on A. baumannii OIFC 109 biofilm in an in vitro wound model. A.
baumannii exposed to MICs of TC/EG were allowed to form a biofilm on a collagen matrix at
37OC. Bacterial counts were enumerated after 24 and 48 h of incubation.Bars with different
superscripts differ from each other (P < 0.05).
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Fig 6. Effect of TC and EG on A. baumannii WC-487 biofilm in an in vitro wound model. A.
baumannii exposed to MICs of TC/EG were allowed to form a biofilm on a collagen matrix at
37OC. Bacterial counts were enumerated after 24 and 48 h of incubation.Bars with different
superscripts differ from each other (P < 0.05).
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Fig 7. Scanning confocal micrographs of Acinetobacter baumannii Naval-17 biofilm
(A) without TC/EG treatment, (B) after treatment with the MIC of trans-cinnamaldehyde (TC;
4.0 mM), (C) after treatment with the MIC of eugenol (EG; 4.0 mM). The bacteria were first
treated with TC and EG and allowed to form a biofilm at 37OC for 48 h on borosilicate glass
coverslip. Live/Dead staining of the biofilm was done with 2.5 M Syto9 and 5 M propidium
iodide.
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Fig 8. Effect of TC and EG on biofilm genes in A. baumannii Naval-17 *(P<0.05)
A. baumannii Naval-17 was exposed to SICs of TC or EG and RT-qPCR was done to test the
effect of PDAs on critical biofilm genes in A. baumannii. Bacteria not exposed to TC/EG served
as control. Bars with * are significantly different from control (P <0.05).
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Fig 9. Effect of TC and EG on biofilm genes in A. baumannii OIFC 109
A.baumannii OIFC 109 was exposed to SICs of TC or EG and RT-qPCR was done to test the
effect of PDAs on critical biofilm genes in A. baumannii. Bacteria not exposed to TC/EG served
as control. Bars with * are significantly different from control (P <0.05).
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Chapter VIII

SUMMARY AND CONCLUSIONS
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Acinetobacter baumannii has emerged as a significant, multi-drug resistant (MDR),
nosocomial pathogen causing meningitis, bacteremia, urinary tract infections and wound
infections in humans. The widespread presence of this pathogen in the environment, including
soil and water, potentially leads to the contamination of foods, especially fresh produce In
addition, A. baumannii is resistant to almost all currently used antibiotics, making the treatment
of infections difficult. This underscores the need for alternative strategies for controlling the
pathogen.
This study investigated the prevalence of MDR A. baumannii on fresh vegetables, and the
efficacy of chlorine as a water disinfectant in killing the bacterium. In addition, the study also
investigated the potential of two plant-derived antimicrobials (PDAs), trans-cinnamaldehyde
(TC) and eugenol (EG), for controlling antibiotic resistance and virulence in A. baumannii. The
first objective of the study investigated the prevalence of MDR A. baumannii on vegetables such
as carrots, lettuce and potatoes collected from farmers’ markets in Connecticut. The results
revealed that out of 100 samples of each vegetable tested, A. baumannii was recovered from only
two samples of potato and one sample of lettuce. Further, no carrot sample was positive for the
bacterium. However, besides A. baumannii, several other MDR, opportunistic human pathogens
such as Burkholderia cepacia, Stenotrophomonas maltophilia and Pseudomonas luteolawere
recovered from the vegetables. Burkholderia cepacia isolates showed a high resistance to
ceftriaxone (91%), colistin-sulphate (83%), erythromycin (79%) and streptomycin (70%);
Pseudomonas luteola to colistin-sulphate (91%) and imipenem (83%); S. maltophilia to colistinsulphate (100%), ceftriaxone (88%), cefepime (66%), erythromycin (66%) and imipenem (55%);
and all isolates of A. baumannii were resistant to imipenem, ceftriaxone, erythromycin and
streptomycin. The results indicated the presence of MDR bacteria, including A. baumannii on
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fresh produce, thereby highlighting the potential health risk to consumers, especially those who
are immune-compromised.
The second objective of this study was to test the efficacy of chlorine as a water
disinfectant in killing A. baumannii. In addition, RT-qPCR was used to determine the effect of
chlorine on the antibiotic resistance genes in A. baumannii. Results revealed that all the tested A.
baumannii strains survived a chlorine concentration up to 4 pm, which typically used for water
disinfection. Further, RT-qPCR analysis revealed an up-regulation of all or some of the antibiotic
resistance genes in the tested A. baumannii isolates, indicating an induction of antibiotic
resistance in the presence of chlorine. This is significant as chlorine is widely used as a sanitizer
for water and fresh produce.
As routine cultural methods of screening A. baumannii from biological materials are
cumbersome, the development of a real-time PCR (RT-qPCR) for rapid and specific detection of
A. baumannii in water and blood was the third objective in the study. The RT-qPCR used a
TaqMan primer-probe set targeting a highly conserved 102-bp DNA sequence of an efflux pump
gene, adeT found in A. baumannii. All tested A. baumannii isolates yielded a 107-bp PCR
product, while none of the negative isolates, including other closely related Acinetobacter
species produced any amplification. The sensitivity of PCR was 3 log10 CFU/ml A. baumannii or
0.1 ng/mL of A. baumannii DNA. However, upon enrichment, the PCR detected 2 log and 1 log
CFU/ml of A. baumannii in water after 6 h and 14 h of incubation at 37oC, respectively.
Beta-lactam antibiotics are the most commonly used antibiotics used in the treatment of
human infections. Since A. baumannii is resistant to most currently known antibiotics, the fourth
objective of the study investigated the efficacy of TC and EG in decreasing A. baumannii’s
resistance to seven -lactam antibiotics. The results from broth dilution assay revealed that both
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TC and EG increased the sensitivity of A. baumannii to all antibiotics tested (P<0.05). In
addition, RT-qPCR data revealed that TC and EG down-regulated the expression of majority of
the genes conferring resistance to beta-lactam antibiotics, especially blaP and adeABC. The
results suggest that TC and EG could potentially be used along with β-lactam antibiotics for
controlling MDR A. baumannii infections; however, their clinical significance needs to be
determined using in vivo studies.
The fifth objective of the study was to investigate the efficacy of TC and EG in decreasing
A. baumannii adhesion to and invasion of normal human keratinocytes, and inhibiting A.
baumannii biofilm formation in an in vitro wound model. Both TC and EG significantly reduced
A. baumannii adhesion to the skin cells by ~2-2.5 log10 CFU/ml and invasion of the cells by ~2-3
log CFU/m compared to controls (P<0.05). Further, both PDAs inhibited biofilm formation by A.
baumannii in the wound model. These results suggest the potential use of TC and EG for treating
A. baumannii wound infections.
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